Abstract
The outcome of an encounter with Mycobacterium tuberculosis (Mtb) depends on the pathogen’s ability to adapt to the variable immune pressures exerted by the host. Understanding this interplay has proven difficult, largely because experimentally tractable animal models do not recapitulate the heterogeneity of tuberculosis disease. We leveraged the genetically diverse Collaborative Cross (CC) mouse panel in conjunction with a library of Mtb mutants to create a resource for associating bacterial genetic requirements with host genetics and immunity. We report that CC strains vary dramatically in their susceptibility to infection and produce qualitatively distinct immune states. Global analysis of Mtb transposon mutant fitness (TnSeq) across the CC panel revealed that many virulence pathways are only required in specific host microenvironments, identifying a large fraction of the pathogen’s genome that has been maintained to ensure fitness in a diverse population. Both immunological and bacterial traits can be associated with genetic variants distributed across the mouse genome, making the CC a unique population for identifying specific host-pathogen genetic interactions that influence pathogenesis.
Research organism: Mouse, Other
Introduction
Infection with Mycobacterium tuberculosis (Mtb) produces heterogeneous outcomes that are influenced by genetic and phenotypic variation in both the host and the pathogen. Classic human genetic studies show that host variation influences immunity to tuberculosis (TB) (Abel et al., 2018; Comstock, 1978). Likewise, the co-evolution of Mtb with different populations across the globe has produced genetically distinct lineages that demonstrate variable virulence traits (Gagneux et al., 2006; Hershberg et al., 2008; Wirth et al., 2008). The role of genetic variation on each side of this interaction is established, yet the intimate evolutionary history of both genomes suggests that interactions between host and pathogen variants may represent an additional determinant of outcome (McHenry et al., 2020). Evidence for genetic interactions between host and pathogen genomes have been identified in several infections (Ansari et al., 2017; Berthenet et al., 2018), including TB (Caws et al., 2008; Holt et al., 2018; Thuong et al., 2016). However, the combinatorial complexity involved in identifying these relationships in natural populations have left the mechanisms largely unclear.
Mouse models have proven to be a powerful tool to understand mechanisms of susceptibility to TB. Host requirements for protective immunity were discovered by engineering mutations in the genome of standard laboratory strains of mice, such as C57BL/6 (B6), revealing a critical role of Th1 immunity. Mice lacking factors necessary for the production of Th1 cells or the protective cytokine interferon gamma (IFNγ) are profoundly susceptible to Mtb infection (Caruso et al., 1999; Cooper et al., 1993; Cooper et al., 1997; Flynn et al., 1993; Saunders et al., 2002). Defects in this same immune axis cause the human syndrome Mendelian Susceptibility to Mycobacterial Disease (MSMD) (Altare et al., 1998; Bogunovic et al., 2012; Bustamante et al., 2014; Filipe-Santos et al., 2006), demonstrating the value of knockout (KO) mice to characterize genetic variants of large effect. Similarly, the standard mouse model has been used to define Mtb genes that are specifically required for optimal bacterial fitness during infection (Bellerose et al., 2020; Sassetti and Rubin, 2003; Zhang et al., 2013).
Despite the utility of standard mouse models, it has become increasingly clear that the immune response to Mtb in genetically diverse populations is more heterogeneous than any single small animal model (Smith and Sassetti, 2018). For example, while IFNγ-producing T cells are critical for protective immunity in standard inbred lines of mice, a significant fraction of humans exposed to Mtb control the infection without producing a durable IFNγ response (Lu et al., 2019). Similarly, IL-17 producing T cells have been implicated in both protective responses and inflammatory tissue damage in TB, but IL-17 has little effect on disease progression in B6 mice, except in the context of vaccination or infection with particularly virulent Mtb (Gopal et al., 2012; Khader et al., 2007). The immunological homogeneity of standard mouse models may also explain why only a small minority of the >4000 genes that have been retained in the genome of Mtb during its natural history promote fitness in the mouse (Bellerose et al., 2020). Thus, homogenous mouse models of TB fail to capture the distinct disease states, mechanisms of protective immunity, and selective pressures on the bacterium that are observed in natural populations.
The Collaborative Cross (CC) and Diversity Outbred (DO) mouse populations are new mammalian resources that more accurately represent the genetic and phenotypic heterogeneity observed in outbred populations (Churchill et al., 2004; Churchill et al., 2012). These mouse panels are both derived from the same eight diverse founder strains but have distinct population structures (Saul et al., 2019). DO mice are maintained as an outbred population and each animal represents a unique and largely heterozygous genome (Keller et al., 2018; Svenson et al., 2012). In contrast, each inbred CC strain’s genome is almost entirely homozygous, producing a genetically stable and reproducible population in which the phenotypic effect of recessive mutations is maximized (Shorter et al., 2019; Srivastava et al., 2017). Together, these resources have been leveraged to identify host loci underlying the immune response to infectious diseases (Noll et al., 2019). In the context of TB, DO mice have been used as individual, unique hosts to identify correlates of disease, which resemble those observed in non-human primates and humans (Ahmed et al., 2020; Gopal et al., 2013; Koyuncu et al., 2021; Niazi et al., 2015). Small panels of the reproducible CC strains have been leveraged to identify host background as a determinant of the protective efficacy of BCG vaccination (Smith et al., 2016) and a specific variant underlying protective immunity to tuberculosis (Smith et al., 2019). While these studies demonstrate the tractability of the DO and CC populations to model the influence of host diversity on infection, dissecting host-pathogen interactions requires the integration of pathogen genetic diversity.
We combined the natural but reproducible host variation of the CC panel with a comprehensive library of Mtb transposon mutants to determine whether the CC population could be used to characterize the interactions between host and pathogen. Using over 60 diverse mouse strains, we report that the CC panel encompasses a broad spectrum of TB susceptibility and immune phenotypes. By leveraging high-resolution bacterial phenotyping known as ‘Transposon Sequencing’ (TnSeq), we quantified the relative fitness of a saturated library of Mtb mutants across the CC panel and specific immunological mouse knockout strains. We report that approximately three times more bacterial genes contribute to fitness in the diverse panel than in any single mouse strain, defining a large fraction of the bacterial genome that is dedicated to adapting to distinct immune states. Association of both host immunological phenotypes and bacterial fitness traits with Quantitative Trait Loci (QTL) demonstrated the presence of discrete Host-Interacting-with Pathogen QTL (HipQTL) that represent inter-species genetic interactions that influence the pathogenesis of this infection. Together, these observations support the CC population as a tractable model of host diversity that greatly expands the spectrum of immunological and pathological states that can be modeled in the mouse.
Results
The spectrum of TB disease traits in the CC exceeds that observed in standard inbred mice
To characterize the diversity of disease states that are possible in a genetically diverse mouse population, we infected a panel of 52 CC lines and the eight founder strains with Mtb. To enable bacterial transposon sequencing (TnSeq) studies downstream, the animals were infected via the intravenous (IV) route with a saturated library of Mtb transposon mutants (infectious dose of 105 CFU), which in sum produce an infection that is similar to the wild-type parental strain (Bellerose et al., 2020; Sassetti and Rubin, 2003). Groups of three to six male mice per genotype were infected and TB disease-related traits were quantified at one-month post-infection. Data from all surviving animals that were phenotyped are provided in Figure 1—source data 1. The bacterial burden after 4 weeks of infection was assessed by plating (colony-forming units, CFU) and quantifying the number of bacterial chromosomes in the tissue (chromosome equivalents, CEQ). These two metrics were highly correlated (r = 0.88) and revealed a wide variation in bacterial burden across the panel (Figure 1A and Figure 1—figure supplement 1). The phenotypes of the inbred founder strains were largely consistent with previous studies employing an aerosol infection (Smith et al., 2016), where the WSB strain was more susceptible than the more standard B6, 129S1/SvlmJ (129), and NOD/ShiLtJ (NOD) strains. Across the entire CC panel, lung bacterial burden varied by more than 1000-fold, ranging from animals that are significantly more resistant than B6, to mice that harbored more than 109 bacteria in their lungs (Figure 1A). Bacterial burden in the spleen also varied several thousand-fold across the panel and was moderately correlated with lung burden (r = 0.43) (Figure 1—figure supplement 1). Thus, the CC panel encompasses a large quantitative range of susceptibility.
Comparing various measures of infection progression showed many expected correlations but also an unexpected decoupling of some phenotypes. As an initial assessment of the disease processes in these animals, we correlated bacterial burden and lung cytokine abundance with measures of systemic disease such as weight loss and sufficient morbidity to require euthanasia (‘earliness of death’). In general, correlations between these metrics indicated that systemic disease was associated with bacterial replication and inflammation (Figure 1B and Figure 1—figure supplement 1). Lung CFU was strongly correlated with weight loss, mediators that enhance neutrophil differentiation or migration (CXCL2 (MIP-2; r = 0.79), CCL3 (MIP-1a; r = 0.77), G-CSF (r = 0.78), and CXCL1 (KC; r = 0.76)), and more general proinflammatory cytokines (IL-6 (r = 0.80) and IL-1α (r = 0.76)) (Figure 1—figure supplement 1). These findings are consistent with previous work in the DO panel, that found both proinflammatory chemokines and neutrophil accumulation to be predictors of disease (Ahmed et al., 2020; Gopal et al., 2013; Koyuncu et al., 2021; Niazi et al., 2015).
The reproducibility of CC genotypes allowed us to quantitatively assess the heritability (h2) of these immunological and disease traits. The percent of the variation attributed to genotype ranged from 56%–87% (mean = 73.4%; (Appendix 1—table 1)). The dominant role of genetic background in determining the observed phenotypic range allowed a more rigorous assessment of strains possessing outlier phenotypes than is possible in the DO population, based on linear regression using studentized residuals that accounts for the intragenotype variation. For example, despite the correlation between lung CFU and weight loss (r = 0.57), several strains failed to conform to this relationship (Figure 1C). In particular, CC030/GeniUnc (p = 0.003), CC040/TauUnc (p = 0.027) and A/J (p = 0.03) lost more weight than their bacterial burdens would predict (Figure 1C; noted by #). Similarly, CXCL1 abundance was higher in CC030/GeniUnc (p = 0.001) and lower in CC056/GeniUnc (p = 0.040), than the level predicted by their respective bacterial burden (Figure 1C; outlier genotypes noted by †). Thus, these related disease traits can be dissociated based on the genetic composition of the host.
The cluster of cytokines that was most notably unrelated to bacterial burden included IFNγ and the interferon-inducible chemokines CXCL10 (IP10), CXCL9 (MIG), and CCL5 (RANTES) (Red cluster in Figure 1B; Figure 1—figure supplement 1) (R < 0.3). Despite the clear protective role for IFNγ (Cooper et al., 1993; Flynn et al., 1993), high levels have been observed in susceptible mice, likely as a result of high antigen load (Barber et al., 2011; Lazar-Molnar et al., 2010). While high IFNγ levels in susceptible animals was therefore expected, it was more surprising to find a number of genotypes that were able to control bacterial replication yet had very low levels of this critically important cytokine (Figure 1D). This observation is likely due the inclusion of two founder lines, CAST/EiJ (CAST) and PWK/PhJ (PWK) that we previously found to display this unusual phenotype (Smith et al., 2016).
To assess the reproducibility of these findings in an aerosol infection model, we tested four CC genotypes that were susceptible by IV infection, including CC027, CC032, CC037, and CC042. We infected groups of 4–6 mice per genotype with H37Rv strain via low-dose aerosol infection (~100 CFU), including B6 mice as resistant controls. At 4-weeks post infection, we quantified lung CFU, lung cytokine abundance and weight loss as measurements of TB disease. Compared to the resistant B6 mice, the selected CC strains demonstrated higher bacterial burden in the lung (Figure 1E) and significant weight loss (Figure 1F), thus validating disease traits as consistent across both route and dose. Likewise, cytokines that were highly correlated with lung burden in the CC screen (Figure 1B, Figure 1—figure supplement 1) were consistent in the aerosol validation study (Figure 1—figure supplement 2). Notably, CXCL1 was consistently high in the susceptible genotypes, as compared to B6 (Figure 1G), and was highly correlated with lung burden by both IV (R = 0.76) and aerosol (R = 0.92) routes. IFNγ levels were variable across the strains (Figure 1H) and did not correlate with lung CFU (R = −0.22), concordant with findings from the CC screen (R = −0.21). Altogether, this survey of TB-related traits demonstrated a broad range of susceptibility and the presence of qualitatively distinct and genetically determined disease states.
TipQTL define genetic variants that control TB immunophenotypes
Tuberculosis ImmunoPhenotype Quantitative Trait Loci (TipQTL), which were associated with TB disease or cytokine traits, were identified and numbered in accordance with previously reported TipQTL (Smith et al., 2019). Of the 32 TB-disease traits, we identified nine individual metrics that were associated with a chromosomal locus. Of these, three were associated with high confidence (p ≤ 0.053), and six other QTL met a suggestive threshold as determined by permutation analysis (p < 0.2; Table 1). Several individual trait QTL occupied the same chromosomal locations. For example, spleen CFU and spleen CEQ, which are both measures of bacterial burden and highly correlated, were associated with the same interval on distal chromosome 2 (Table 1, Tip5; Figure 2A and C). IL-10 abundance was associated with two distinct QTL (Table 1). While IL-10 was only moderately correlated with spleen CFU (R = 0.48), one of its QTL fell within the Tip5 bacterial burden interval on chromosome 2 (Figure 2A and C). At this QTL, the NOD haplotype was associated with high values for all three traits (Figure 2E). Similarly, the strongly correlated traits, CXCL1 abundance and lung CFU, were individually associated to the same region on chromosome 7 (Table 1, Tip8; Figure 2B and D). In this interval, the CAST haplotype was associated with both low bacterial burden and CXCL1 (Figure 2F). At both Tip5 and Tip8, we found no statistical evidence that the positions of the associated QTL were different (Tip5 p = 0.55; Tip8 p = 0.27; 400 bootstrap samples) (Boehm et al., 2019). These observations support the role of a single causal variant at each locus that is responsible for a pleiotropic trait. Coincident mapping can provide both additional statistical support for QTL (p values by Fisher’s combined probability test: Chr 7, p = 0.067; Chr 2, p = 0.041) and suggests potential mechanisms of disease progression.
Table 1. Disease-related Tuberculosis ImmunoPhenotype QTL (TipQTL).
QTL | Trait | Chr | LOD | p value | Interval start (Mb) | Peak (Mb) | Interval end (Mb) |
---|---|---|---|---|---|---|---|
Tip5 | Spleen CEQ | 2 | 9.14 | 2.38E-02 | 174.29 | 178.25 | 178.25 |
Tip5 | Spleen CFU | 2 | 7.04 | 2.19E-01 | 73.98 | 174.29 | 180.10 |
Tip6 | IL-9 | 2 | 8.61 | 4.52E-02 | 33.43 | 41.4 | 41.48 |
Tip6 | IL-9 | 2 | 7.85 | 1.26E-01 | 22.77 | 24.62 | 25.65 |
Tip7 | IL-17 | 15 | 7.84 | 5.27E-02 | 67.98 | 74.14 | 82.11 |
Tip8 | CXCL1 | 7 | 7.57 | 1.06E-01 | 30.43 | 45.22 | 46.72 |
Tip8 | Lung CFU | 7 | 7.47 | 1.17E-01 | 31.06 | 37.78 | 45.22 |
Tip9 | IL-10 | 17 | 7.16 | 1.85E-01 | 80.98 | 82.47 | 83.55 |
Tip10 | Lung CFU | 15 | 7.13 | 1.86E-01 | 77.00 | 78.16 | 78.70 |
Figure 2. Host loci underlying TB disease-related traits.
(A–B) Whole genome QTL scans of (A) spleen CEQ, spleen CFU and IL-10 (B) lung CFU and CXCL1. (C) Zoom of chromosome two loci. (D) Zoom of chromosome seven loci. Thresholds were determined by permutation analysis; solid line, middle dashed line, and lowest dotted lines represent p = 0.05, p = 0.1, and p = 0.2. (E–F) Scaled phenotype value per haplotype at the QTL peak marker. Each dot represents the mean value for a genotype.
A number of factors can limit the statistical significance of QTL identified in the CC population, including small effect sizes, limited genotype availability, and the genetic complexity of the trait. We took an F2 intercross approach to independently assess the importance of the lung CFU QTL on chromosomes 7 and 15 (Tip8 and Tip10, Table 1). Given that the associations at both QTL were driven by the CAST haplotype (Figure 2F), we generated an F2 population based on two CC strains, CC029/Unc and CC030/GeniUnc, that contained CAST sequence at Tip8 and Tip10, respectively (Figure 3A and B). The F2 validation cohort (n = 251 mice) were genotyped (Sigmon et al., 2020) and infected with the Mtb strain H37Rv (IV route with infectious dose of 105 CFU, as per the original CC screen). At 1 month post infection, lung CFU was quantified, and we conducted QTL mapping in R/qtl2 (Broman et al., 2019) to identify host loci underlying bacterial burden in the lung. We identified a QTL significantly associated with lung CFU (LOD = 6.81; p < 0.05; 10,000 permutations) on chromosome seven that overlapped with Tip8 (peak position Chr7:28.6 Mb), thus validating this locus as a main driver of bacterial burden. In this reduced complexity cross, we did not observe a QTL on chromosome 15 (Tip10). This may be due to the B6 haplotype at this locus in CC030, which did not represent the strongest phenotypic contrast to CAST. Additionally in the mapping validation study, we identified a new resistance (low lung CFU) locus on chromosome 8 (LOD = 4.08; peak position Ch8:116.1 Mb), driven by the CC029 cross partner with the CAST haplotype. This QTL was not present in the original CC screen, probably due to the low representation of the CAST haplotype at that marker in the CC cohort tested. Altogether, this intercross strategy validated Tip8 as a strong predictor of lung CFU, though rigorous validation of Tip10 may require a more optimal pairing of parental strains.
Figure 3. An F2 intercross approach to validate QTL underlying lung CFU.
(A) Haplotypes of CC030 and CC029 CC strains at Chr7 (Tip 8) and (B) at Chr15 (Tip10). The F2 population (n = 251) based on these founders were genotyped, infected with Mtb (105 infectious dose by IV route, as per the original CC screen), and lung CFU was quantified at 1 month post-infection. (C) QTL mapping identified genome-wide significant (p < 0.05) loci on Chr7 (LOD = 6.81; peak position on Chr7 at 28.6 Mb) overlapping with Tip8 and a new locus on Chr8 (LOD = 4.08; peak position Ch8:116.1 Mb). Thresholds were determined by permutation analysis; solid line, middle dashed line, and lowest dotted lines represent p = 0.05, p = 0.1, and p = 0.2. Source files of F2 genotypes are available in Figure 3—source data 1; phenotypes are available in Figure 3—source data 1.
Mtb adapts to diverse hosts by utilizing distinct gene repertoires
This survey of disease-associated traits demonstrated that the CC panel encompasses a number of qualitatively distinct immune phenotypes. To determine if different bacterial functions were necessary to adapt to these conditions, we leveraged transposon sequencing (TnSeq) as a high-resolution phenotyping approach to estimate the relative abundance of individual Mtb mutants after selection in each CC host genotype. To serve as benchmarks of known immunological lesions, we also performed TnSeq in B6 mice that were lacking the mediators of Th1 immunity, lymphocytes (Rag2-/-) and IFNγ (Ifng-/-), or were lacking the immunoregulatory mediators that control disease by inhibiting inflammation, nitric oxide synthase (Nos2-/-) (Mishra et al., 2013) or the NADPH phagocyte oxidase (Cybb-/-) (Olive et al., 2018). The relative representation of each Mtb mutant in the input library versus the output library recovered from each mouse spleen after one-month of infection was quantified by TnSeq (Long et al., 2015). A total of 123 saturated Mtb transposon libraries (representing >50,000 independent insertion events) were sequenced, capturing 60 distinct mouse genotypes (Figure 4—source data 1).
From this TnSeq screen, we identified 214 Mtb genes that are required for growth or survival of Mtb in B6 mice, based on significant underrepresentation of the corresponding mutant after four weeks of in vivo selection. Eighty-seven percent of these genes overlapped with a similar previous analysis in BALB/c mice (Bellerose et al., 2020) highlighting the specificity of the analysis. All but one of the genes found to be important in B6, were also required in the larger mouse panel, further increasing confidence in this Mtb gene set (Figure 4A and B). While the total number of genes found to be necessary in each genotype across the diversity panel was largely similar, the composition of these Mtb gene sets varied considerably. As more CC strains, and presumably more distinct immune states, were included in the analysis, the cumulative number of bacterial genes necessary for growth in these animals also increased. This cumulative gene set plateaued at ~750, after the inclusion of approximately 20–25 mouse genotypes (Figure 4A). Simply sampling additional libraries of B6 does not appreciably increase the number of genes identified as necessary for growth in that genotype (Figure 4—figure supplement 1), supporting the presence of alternative selective environments across the CC mice. The number of genes important for fitness in the CC panel far outnumbered the 380 genes identified in the B6 and immunodeficient KO strains combined (Figure 4B and Figure 4—source data 1).
Figure 4. Mtb genetic requirements vary across diverse hosts.
(A) The number of Mtb genes required for growth or survival in each diverse mouse strain across the panel (Qval ≤0.05). Orange indicates the mutants required for each strain; turquoise shows the cumulative requirement as each new host strain is added. (B) Venn diagram showing the composition of Mtb gene sets required in each category of host (white, largest circle), only required in the CC panel (gray), required in specific immunological KO mice (blue) and genes required in B6 mice (red). Note, 1* is required in B6 and KO. In order to be called ‘essential’ in each mouse strain, Mtb genes had to be significantly over or underrepresented in at least two genotypes. (C) Each box shows log2 fold change (LFC) of individual mutants from the TnSeq screen relative to the input pool in indicated mouse strains (top); log2 fold change of the indicated deletion mutants relative to WT from a pooled mutant validation infection (middle panel); relative fitness calculated from (middle panel) to account for generation differences in each host due to differential growth rate. Bars are the average of 3–6 mice per mutant/genotype ± SD. Statistical differences between mini-pool validation groups was assessed by Welch’s t-test. (D) Lung CFU and spleen CFU from single strain low-dose aerosol infections of ∆bioA mutant or WT H37Rv strain in B6 and CAST mice at 2- or 5 weeks post-infection. Dashed line indicates the limit of detection. Each point indicates the average CFU ± SD of 4–5 mice per group. Statistical differences between groups were assessed by mixed effects models (Tukey’s test). (E) Log2 fold change of selected mutants from the TnSeq screen across the CC panel and immunological KO mice. Each dot represents the average LFC per mouse genotype; KO mouse strains (on a B6 background) dots are shown larger for clarity. All mice in the large CC TnSeq screen were male; mice in the ∆bioA aerosol validation were female; mice in the mini-pool validation studies were male and female with no significant differences detected. Source file of the TnSeq screen is available in Figure 4—source data 1; source count data of the TnSeq validation experiment is available in Figure 4—source data 2.
Figure 4—figure supplement 1. Sampling additional B6 libraries does not appreciably increase the estimate of genes necessary for growth.
To verify that our TnSeq study accurately assessed the effect of the corresponding loss-of-function alleles, we assessed the phenotypes of selected bacterial deletion mutants in a small set of mouse genotypes that were predicted to produce differential selection. Individual Mtb mutants lacking genes necessary for ESX-1 Type VII secretion (eccB1), siderophore-mediated iron acquisition (mbtA), phosphate transport (pstC2), glycerol catabolism (glpK), and RNA processing (rnaseJ) were generated and tagged with a unique molecular barcode. These mutants were combined with a barcoded wild-type parental strain, and the resulting ‘mini-pool’ was subjected to in vivo selection after IV infection of a sub-panel of mouse strains, as in the original screen. The relative abundance of each mutant was determined by sequencing the amplified barcodes and data from all reliably detected strains is shown in (Figure 4; Figure 4—source data 2). In each case, the difference in relative abundance predicted by TnSeq was reproduced with deletion mutants. In this simplified system, we were able to accurately quantify the expansion of the bacterial population and calculate the ‘fitness’ of each mutant relative to the wild-type strain. Fitness reflects the inferred doubling time of the mutant, where a fitness of 1 is defined as wild-type, and 0 represents a complete lack of growth. Even by this metric, the deletion mutants displayed the differences in fitness between mouse strains that was predicted by TnSeq (Figure 4C). The statistical significance of these differences in abundance or fitness were similar for each mutant (between p = 0.009 and p = 0.06), except for mbtA where the variation was higher, and confidence was modestly lower (p = 0.07 and p = 0.12). This study also allowed us to estimate the sensitivity of the TnSeq method, which could detect even the 30% fitness defect of the ∆glpK strain between the B6 and CC018 animals (Figure 4C), a defect that was not observed in previous studies in BALB/c mice (Bellerose et al., 2019; Pethe et al., 2010).
To also validate TnSeq predictions in a single-strain aerosol infection model, we used a biotin biosynthetic mutant. bioA is necessary for biotin production and is essential for growth in B6 mice (Woong Park et al., 2011). Our TnSeq study (Figure 4—source data 1) predicted this mutant was less attenuated in the CAST background (ratio of input/selected = 12.1) than in the B6 strain (ratio of input/selected = 42.2). Two weeks after aerosol infection, we found that the ∆bioA mutant was cleared from the lungs and spleen of B6 mice but displayed similar growth to wild-type in the lungs of CAST mice (Figure 4D). By 6 weeks post-infection the ∆bioA mutant had also been largely cleared from the lungs of CAST (Figure 4D). Thus, while TnSeq was unable predict long-term outcome, it provided an accurate assessment of relative growth attenuation in these host backgrounds.
The immunological diversity of CC mice is reflected in the pathogen’s genetic requirements
The distribution of Mtb’s requirements across the mouse panel suggested the presence of two broad categories of genes. A set of 136 ‘core’ virulence functions were required in the majority of mouse genotypes, and a second larger set of 607 ‘adaptive’ virulence genes were required in only a subset of lines (Figure 4—source data 1). The core functions included a number of genes previously found to be important in B6 mice, including those necessary for the synthesis of essential cofactors, such as pyridoxine (pdx1) (Dick et al., 2010); for the acquisition of nutrients, such as siderophore-bound iron (irtAB) (Ryndak et al., 2010), cholesterol (mce4) (Pandey and Sassetti, 2008), glutamine (glnQ and rv2563) (Bellerose et al., 2020) and for Type VII secretion (ESX1 genes) (Stanley et al., 2003). Despite the importance of these core functions, a large range in the relative abundance of these mutants was observed across the panel, and in some cases specific immunological requirements could be discerned. Mutants lacking the major structural components of the ESX1 system were attenuated for growth in B6 mice, as expected. This requirement was enhanced in mice lacking Rag2, Ifng, or Nos2 (Figure 4E), consistent with the preferential role of ESX1 during the initial stage of infection before the initiation of adaptive immunity (Stanley et al., 2003), which is prolonged in these immunodeficient strains. In contrast, the attenuation of mutants lacking the glnQ encoded glutamine uptake system was relieved in all four immunodeficient mouse lines (Figure 4E). In both cases, the differential mutant abundance observed in these KO mice was reproduced, or exceeded, in the CC panel.
The adaptive virulence functions included a number of Mtb genes previously thought to be dispensable in the mouse model and were only necessary in CC strains. For example, the alkyl hydroperoxide reductase, AhpC has been proposed to function with the adjacently encoded peroxiredoxin, AhpD and is critical for detoxifying reactive nitrogen intermediates in vitro (Chen et al., 1998; Hillas et al., 2000). However, deletion of ahpC has no effect on Mtb replication in B6 or BALB/c mice (Springer et al., 2001), and we confirmed that ahpC and ahpD mutations had no effect in any of the B6-derived strains. In contrast, ahpC, but not ahpD mutants were highly attenuated in a small number of CC strains (Figure 4E). Similarly, the four phospholipase C enzymes of Mtb (plcA-D) are implicated in both fatty acid uptake and modifying host cell membranes but are dispensable for replication in B6 mice (Le Chevalier et al., 2015). Again, while we found that none of these genes were required in B6-derived KO mouse strains, the plcD mutants were specifically underrepresented in a number of CC mice (Figure 4E). These individual bacterial functions are controlled by regulatory proteins, such as the extracytoplasmic sigma factors. Despite the importance of these transcription factors in the response to stress, only sigF has consistently been shown to contribute to bacterial replication in standard inbred lines of mice (Geiman et al., 2004; Rodrigue et al., 2006). Our study assessed the importance of each sigma factor in parallel across diverse host genotypes and identified a clear role for several of these regulators. sigC, sigI, sigF, sigL, and sigM mutants were each significantly underrepresented in multiple strains of mice, and several of these phenotypes were only apparent in the diverse CC animals (Figure 4E). In sum, the 607 adaptive functions that are differentially required across the host panel represents nearly 20% of the non-essential gene set of Mtb, suggesting that a significant fraction of the pathogen’s genome is dedicated to maintaining optimal fitness in diverse host environments.
Differential genetic requirements define virulence pathways in Mtb
To more formally investigate the distinct stresses imposed on the bacterial population across this host panel, we characterized the differentially required bacterial pathways. Upon performing each possible pairwise comparison between the in vivo selected mutant pools, we found 679 mutants whose representation varied significantly (FDR < 5%) in at least two independent comparisons (Figure 4—source data 1). We then applied weighted gene correlation network analysis (WGCNA) (Langfelder and Horvath, 2008) to divide the mutants into 20 internally-correlated modules. Further enrichment of these modules for the most representative genes (intramodular connectivity >0.6) revealed that nearly all modules contained genes that are encoded adjacently in the genome and many of these modules consisted of genes dedicated to a single virulence-associated function (Figure 5A). Module three contains two distally encoded loci both known to be necessary for ESX1-mediated protein secretion, the primary ESX1 locus (rv3868-rv3883) and the espACD operon (rv3616c-rv3614c). Similarly, other modules consisted of genes responsible for ESX5 secretion (Module 7), mycobactin synthesis (Module 4), the Mce1 and Mce4 lipid importers (Modules 5 and 16), phthiocerol dimycocerosate synthesis (PDIM, Module 8), PDIM transport (Module 16), and phosphate uptake (Module 14). The 20 genes assigned to Module six included two components of an important oxidative stress resistance complex (sseA and rv3005c) and were highly enriched for mutants predicted to be involved in this same process via genetic interaction mapping (11/20 genes were identified in Nambi et al., 2015, a statistically significant overlap [p < 2.8e-10 by hypergeometric test]). Thus, each module represented a distinct biological function.
Figure 5. Mtb virulence pathways associate with distinct host immune pressures.
(A) Weighted gene correlation network analysis (WGCNA) of the 679 Mtb genes that significantly vary across the diverse mouse panel. The most representative genes of each module (intramodular connectivity >0.6) are shown. (B) Mouse genotypes were clustered based on the relative abundance of the 679 variable Mtb mutants. The six major clusters (Cluster A-F) were associated with both CFU and the relative abundance of mutants in each bacterial module (1-20; right hand-side with known functions). Statistical analysis is described in Methods. Yellow shading indicates clusters associated with lung CFU. * indicate modules significantly associated with specific mouse clusters (p < 0.05).
Figure 5—figure supplement 1. Module-trait associations.
Many pathway-specific modules contained genes that represented novel functional associations. For example, the gene encoding the sigma factor, sigC, was found in Module one along with a non-ribosomal peptide synthetic operon. Previous genome-wide ChIP-seq and overexpression screens support a role for SigC in regulating this operon (Minch et al., 2015; Turkarslan et al., 2015). Similarly, rv3220c and rv1626 have been proposed to comprise an unusual two-component system that is encoded in different regions of the genome (Morth et al., 2005). Both of these genes are found in Module 2, along with the PPE50 and PPE51 genes that encode at least one outer membrane channel (Wang et al., 2020; Figure 5A). In both cases, these associations support both regulatory and obligate functional relationships between these genes. Six of the 20 modules were not obviously enriched for genes of a known pathway, demonstrating that novel virulence pathways are important for adapting to changing host environments.
To explore the complexity of immune environments in the CC, we used the TnSeq profiles of the 679 differentially fit Mtb mutants to cluster the mouse panel into six major groups of host genotypes (Figure 5B). One mouse cluster was significantly associated with high CFU (Cluster F, Figure 5B), which contained susceptible Nos2-/-, Cybb-/-, Ifng -/-, and Rag2-/- animals. This high CFU cluster was associated with alterations in a diverse set of bacterial modules and corresponded to an increased requirement for lipid uptake (Modules 5 and 16) and ESX1, consistent with previous TnSeq studies in susceptible Nos2-/- and C3HeB/FeJ mice (Mishra et al., 2017). In addition, we identified a significant reduction in the requirement for the oxidative stress resistance (Module 6) in the highest CFU cluster. Despite these associations between bacterial genetic requirements and susceptibility, the clustering of mouse genotypes was largely independent of overall susceptibility. Similarly, while Module one was significantly associated with high IFNγ levels, other bacterial fitness traits were not highly correlated with cytokine abundance (Figure 5—figure supplement 1). Instead, each major mouse cluster was associated with a distinct profile of Mtb genetic requirements. This observation supported the presence of qualitatively distinct disease states and complex genetic control of immunity.
Identification of genome-wide host interacting with pathogen QTL (HipQTL)
To investigate the host genetic determinants of the bacterial microenvironment, we leveraged TnSeq as a high-resolution phenotyping platform to associate Mtb mutant fitness profiles with variants in the mouse genome. When the relative abundance of each Mtb mutant phenotype was considered individually, the corresponding ‘Host Interacting with Pathogen QTL’ (HipQTL) were distributed across the mouse genome (Figure 6A). Forty-one of these traits reached an unadjusted p-value threshold of 0.05 and can be considered as robust for single hypothesis testing (Hip1-41, Table 2). These included HipQTL associated with ahpC (Hip12) and eccD1 (Hip22), that explain at least a portion of the observed variable abundance of these Mtb mutants (Figure 4E). In order to reduce complexity and increase the power of this analysis, we performed QTL mapping based on the first principal component of each of the previously defined modules of Mtb virulence pathways (Figure 5A). Three of these ‘eigentraits’ were associated with QTL at a similar position on chromosome 10 (Figure 6B), corresponding to Module 3 (TypeVII secretion, ESX1), Module 4 (mycobactin synthesis, mbt), or Module 16 (cholesterol uptake, mce4). In all three cases, a single mutant from the module was independently associated with a QTL at the same position as the module eigentrait (Table 2; Hip21, Hip22, Hip24), and all genes in the corresponding network cluster (Figure 5A) mapped to the same location (Figure 6C–E). While not all individual traits mapped with high confidence, the coincidence of these multiple QTL was statistically significant (Figure 6B).
Figure 6. Identification of ‘Host Interacting with Pathogen’ QTL mapping (HipQTL).
(A) Manhattan plot of single Mtb mutant QTL mapping across the mouse genome. Each dot represents an individual Mtb mutant plotted at the chromosomal location of its maximum LOD score. Red dashed line indicates p < 0.01; Blue p < 0.05. (B) Chromosome 10 QTL (in Mb) corresponding to Mtb eigentraits identified in network analysis in Figure 5. Module 3 (Type VII secretion, ESX1 operon; orange), Module 4 (Mycobactin synthesis, mbt; green) and Module 16 (Cholesterol uptake, mce4; purple) are shown. Solid and dotted lines indicated p = 0.05 and p = 0.1, respectively. Chromosomal position is in megabase units (Mb). (C–E) QTL mapping of single Mtb mutants corresponding to the (C) ESX1 module, (D) mbt module and (E) mce4 modules. Coincidence of multiple QTL was assessed by the NL-method of Neto et al., 2012. Thresholds shown are for N = 9, N = 8, and N = 6 for panels C, D, and E, respectively. Chromosomal position is in megabase units (Mb). (F) Parental founder effects underlying Module 3, 4, and 16 QTL. Allele effects were calculated at the peak LOD score marker on chromosome 10. (G) Distribution of log2 fold change (LFC) of representative single mutants from each module; eccCa1 (ESX1 module), mbtE (mbt module), and mce4F (mce4 module) relative to in vitro. Each dot is the LFC of the specified mutant in each CC mouse strain. Box and whiskers plots of each trait indicate the median and interquartile range. (H) Spleen CEQ and Spleen CFU for CC strains (box plots as in G). Mouse values are grouped by the parental haplotype allele series underlying the chromosome 10 Hip42 locus (NOD/WSB vs AJ/B6/NZO). Each dot represents the average CFU/CEQ of each CC genotype. Statistical differences in disease-associated traits and distinct haplotypes groups were assessed by t-test. LOD, logarithm of the odds; LFC, log2 fold change; CEQ, chromosomal equivalents; CFU, colony-forming units.
Table 2. HipQTL for single Mtb mutant QTL and eigentrait/module QTL.
QTL | Trait | Mtb ORF ID | Module # | LOD | P value | Chr | Start (Mb) | Peak (Mb) | End (Mb) |
---|---|---|---|---|---|---|---|---|---|
Hip1 | rv0770 | RVBD_0770 | mod17 | 9.81 | 5.61E-03 | 1 | 40.43 | 42.73 | 43.32 |
Hip2 | rv0309 | RVBD_0309 | mod13 | 7.95 | 3.22E-02 | 1 | 57.99 | 58.18 | 62.79 |
Hip3 | rv3657c | RVBD_3657 c | mod15 | 7.90 | 4.95E-02 | 1 | 136.39 | 138.24 | 143.60 |
Hip4 | rv0110 | RVBD_0110 | mod18 | 7.79 | 4.39E-02 | 2 | 170.67 | 174.00 | 178.84 |
Hip5 | rv3577 | RVBD_3577 | mod7 | 9.23 | 3.83E-02 | 3 | 3.32 | 10.03 | 14.67 |
Hip6 | rv3005c | RVBD_3005 c | mod6 | 8.03 | 3.75E-02 | 3 | 20.31 | 26.12 | 26.12 |
Hip7 | dinX | RVBD_1537 | mod15 | 9.97 | 5.38E-03 | 3 | 26.99 | 30.29 | 33.85 |
Hip8 | fadA6 | RVBD_3556 c | mod5 | 8.74 | 1.01E-02 | 3 | 29.23 | 35.22 | 37.11 |
Hip9 | dinX | RVBD_1537 | mod15 | 9.22 | 1.60E-02 | 3 | 36.22 | 36.83 | 38.27 |
Hip10 | rv2707 | RVBD_2707 | mod6 | 8.17 | 4.21E-02 | 3 | 100.90 | 103.23 | 115.82 |
Hip11 | rv3701c | RVBD_3701 c | mod6 | 7.90 | 3.38E-02 | 4 | 74.00 | 78.25 | 87.00 |
Hip12 | ahpC | RVBD_2428 | mod13 | 8.12 | 2.14E-02 | 6 | 19.75 | 22.21 | 23.31 |
Hip13 | umaA | RVBD_0469 | mod20 | 8.32 | 2.31E-02 | 7 | 117.87 | 118.41 | 120.15 |
Hip14 | rv2566 | RVBD_2566 | mod15 | 7.86 | 4.55E-02 | 7 | 123.21 | 126.67 | 126.67 |
Hip15 | rv3173c | RVBD_3173 c | mod5 | 8.17 | 3.03E-02 | 7 | 137.41 | 138.36 | 138.36 |
Hip16 | rv3173c | RVBD_3173 c | mod5 | 8.12 | 3.28E-02 | 7 | 139.15 | 140.76 | 141.88 |
Hip17 | rv3502c | RVBD_3502 c | mod5 | 8.16 | 3.17E-02 | 9 | 15.91 | 16.33 | 18.72 |
Hip18 | mycP1 | RVBD_3883 c | mod3 | 9.09 | 3.66E-03 | 9 | 28.47 | 29.45 | 31.10 |
Hip19 | rv0057 | RVBD_0057 | mod6 | 8.39 | 3.79E-02 | 9 | 36.78 | 40.07 | 40.36 |
Hip20 | hycE | RVBD_0087 | mod20 | 8.21 | 1.40E-02 | 9 | 47.40 | 47.93 | 51.80 |
Hip21 | mbtA | RVBD_2384 | mod4 | 8.30 | 2.05E-02 | 10 | 64.48 | 68.09 | 75.42 |
Hip22 | eccD1 | RVBD_3877 | mod3 | 8.08 | 3.08E-02 | 10 | 64.56 | 68.12 | 71.04 |
Hip23 | rv2989 | RVBD_2989 | mod12 | 9.16 | 1.67E-02 | 10 | 74.30 | 77.63 | 81.03 |
Hip24 | mce4A | RVBD_3499 c | mod16 | 7.91 | 4.12E-02 | 10 | 78.88 | 81.36 | 88.25 |
Hip25 | treS | RVBD_0126 | mod7 | 7.94 | 3.04E-02 | 11 | 20.80 | 36.14 | 44.06 |
Hip26 | pckA | RVBD_0211 | mod3 | 7.67 | 4.74E-02 | 11 | 85.95 | 89.78 | 91.75 |
Hip27 | aspB | RVBD_3565 | mod7 | 8.32 | 3.66E-02 | 11 | 114.69 | 116.99 | 117.08 |
Hip28 | rv1227c | RVBD_1227 c | mod17 | 9.16 | 4.64E-02 | 12 | 25.23 | 25.23 | 28.54 |
Hip29 | rv0219 | RVBD_0219 | mod20 | 7.94 | 3.09E-02 | 12 | 40.65 | 42.65 | 47.22 |
Hip30 | rv3643 | RVBD_3643 | mod8 | 8.89 | 1.04E-02 | 13 | 95.43 | 97.08 | 97.79 |
Hip31 | ansA | RVBD_1538 c | mod11 | 8.28 | 3.32E-02 | 13 | 96.82 | 97.79 | 99.09 |
Hip32 | echA19 | RVBD_3516 | mod20 | 9.68 | 3.95E-02 | 13 | 113.20 | 114.59 | 117.64 |
Hip33 | rv1836c | RVBD_1836 c | mod15 | 9.19 | 1.75E-02 | 14 | 74.94 | 76.40 | 76.43 |
Hip34 | rv2183c | RVBD_2183 c | mod11 | 7.75 | 4.84E-02 | 16 | 12.18 | 14.06 | 17.92 |
Hip35 | rv1178 | RVBD_1178 | mod6 | 8.19 | 4.76E-02 | 17 | 80.92 | 80.92 | 83.23 |
Hip36 | rv0492c | RVBD_0492 c | mod17 | 8.90 | 3.18E-02 | 18 | 5.85 | 5.85 | 12.40 |
Hip37 | cysM | RVBD_1336 | mod12 | 8.47 | 8.67E-03 | 19 | 4.20 | 6.46 | 6.46 |
Hip38 | atsA | RVBD_0711 | mod1 | 8.58 | 1.38E-02 | 19 | 31.21 | 37.86 | 37.93 |
Hip39 | galE2 | RVBD_0501 | mod6 | 8.10 | 2.85E-02 | X | 6.01 | 6.01 | 9.12 |
Hip40 | pks11 | RVBD_1665 | mod17 | 8.25 | 1.94E-02 | X | 50.43 | 51.75 | 52.29 |
Hip41 | pknK | RVBD_3080 c | mod17 | 8.73 | 3.79E-02 | X | 95.01 | 102.02 | 130.04 |
Hip42 | Module 3 | ESX1 operon | mod3 | 7.80 | 5.38E-02 | 10 | 64.7 | 68.27 | 77.07 |
Hip42 | Module 4 | Mycobactin (mbt) | mod4 | 7.79 | 5.05E-02 | 10 | 65.23 | 69.94 | 74.30 |
Hip43 | Module16 | mce4 operon | mod16 | 7.53 | 7.97E-02 | 10 | 74.30 | 81.36 | 87.61 |
Hip44 | Module 19 | unclassified | Module 19 | 7.64 | 1.39E-01 | 11 | 60.87 | 62.20 | 63.26 |
Hip45 | Module 10 | Transcriptional regulation | Module 10 | 6.95 | 1.04E-01 | 15 | 100.39 | 102.25 | 103.36 |
Hip46 | Module 10 | Transcriptional regulation | Module 10 | 6.32 | 2.54E-01 | 19 | 32.74 | 32.87 | 37.48 |
Both the relative positions of the module-associated QTL and the associated founder haplotypes indicated that a single genetic variant controlled the abundance of ESX1 and mbt mutants (Hip42). Specifically, we found no statistical support for differentiating these QTL based on position (p = 0.93) (Boehm et al., 2019) and the same founder haplotypes were associated with extreme trait values at both loci, though they had opposite effects on the abundance of ESX1 mutants and mbt mutants (Figure 6F). We conclude that a single haplotype has a pleiotropic effect on Mtb’s environment and has opposing effects of the requirement for mycobactin synthesis and ESX1 secretion. The relationship between this variant and the mce4-associated QTL (Hip43) was less clear, as the statistical support for independent QTL was weak (ESX1 and mce4 QTL p = 0.17; mbt and mce4 QTL p = 0.08) and the effects of founder haplotypes were similar but not identical (Figure 6F). Some of this ambiguity may be related to the relatively small range in trait values for mce4, compared to either ESX1 or mbt (Figure 6G). Based on this data, we report two distinct HipQTL in this region (Hip42 and 43; Table 2).
Two TipQTL overlapped with HipQTL (Figure 7; Tip5/Hip4 on chromosome two and Tip9/Hip35 on chromosome 17), suggesting specific interactions between bacterial fitness and immunity. However, most Tip- and HipQTL were distinct, indicating that the fitness of sensitized bacterial mutants can be used to detect genetic variants that subtly influence the bacterial environment but not overtly alter disease. We chose to further investigate whether HipQTL might alter overall bacterial disease using the most significant HipQTL on chromosome 10 (Hip42). We found that the founder haplotypes associated with extreme trait values at this QTL could differentiate CC strains with significantly altered total bacterial burden, and the NOD and WSB haplotypes were associated with higher bacterial numbers (p = 0.0085 for spleen CEQ; P = 0.027 for spleen CFU; Figure 6H). Thus, not only could the HipQTL strategy identify specific interactions between host and bacterial genetic variants, but it also appears to be a sensitive approach for identifying host loci that influence the trajectory of disease.
Figure 7. Visual representation of all Tip and HipQTL mapped in the CC TnSeq infection screen.
Tuberculosis ImmunoPhenotypes (Tip) QTL (QTL mapped by disease-associated traits in CC mice), are shown in green. TipQTL mapped by separate traits that share similar founder effects were considered to be the same QTL and were named accordingly. Host Interacting with Pathogen (Hip) QTL, (QTL mapped by individual TnSeq mutant relative abundance profiles), are shown in purple. After WGCNA mutant clustering and mapping with representative eigengenes from each module, QTL mapped by module eigengenes are shown in magenta.
Identifying candidate genes underlying QTL
A pipeline was designed to prioritize genetic variants based on genomic and tuberculosis disease criteria. We concentrated on three QTL: two that were highly significant and with clear allele effects (Tip5, Hip42), and the Tip8 locus which we validated by intercross. For each QTL region, we identified genes that belonged to a differentially expressed transcriptional module in mouse lungs following Mtb infection (Moreira-Teixeira et al., 2020). Next, we identified genetic variants segregating between the causal CC haplotypes in the gene bodies corresponding to these transcripts, and prioritized missense or nonsense variants.
For the Tip5 QTL underlying CEQ, CFU, and IL-10 levels, we identified nine candidate genes with regulatory or splicing variants and two genes with missense variants specific to the NOD haplotype. Of these candidates, cathepsin Z (Ctsz) encodes a lysosomal cysteine proteinase and has previously been associated with TB disease risk in humans (Adams et al., 2011; Cooke et al., 2008). The QTL underlying lung CFU and CXCL1 abundance (Tip8), which was driven solely by the genetically divergent CAST founder haplotype, contained over 50 genes (Table 3) and will need further refinement. The QTL associated with the abundance of ESX1 and mbt mutants (Hip42) had a complex causal haplotype pattern (AJ/B6/NZO vs. 129/CAST/PWK vs. NOD/WSB) suggesting multiple variants might be impacting common genes. Within this interval, we identified 13 genes expressed in response to Mtb infection, three of which had SNPs fully or partially consistent with at least one of the identified causal haplotype groups (Table 3). Ank3 contains several SNPs in the 3’ UTR and other non-coding exons that differentiated NOD/WSB from the other haplotypes. Similarly, Fam13c had two missense mutations following the same haplotype pattern. For the AJ/B6 haplotype state, we identified a missense mutation and several variants in the 3’ UTR of Rhobtb1, which belongs to the Rho family of the Ras superfamily of small GTPases (Goitre et al., 2014). Overall, the evidence supports a role for Rhobtb1 in a monogenic effect at the chromosome 10 locus. This evidence includes both protein coding differences dividing AJ/B6 from the other haplotypes, a potential expression/transcript regulatory difference that segregates the NOD/WSB state from the remaining parental haplotypes, and a plausible role for this gene in controlling intracellular trafficking (Long et al., 2020) and the opposing requirements for ESX1 and mycobactin.
Table 3. Candidate genes within QTL regions.
Tip5 | Tip8 | Hip42 | |
---|---|---|---|
Ctsz | Fxyd5* | Siglecg | Ank3 |
Tubb1 | Fxyd1 | Nkg7 | Cdk1 |
Atp5e | Lgi4 | Cd33* | Tmem26 |
Prelid3b | Fxyd3 | Siglece* | Slc16a9 |
Zfp831* | Hpn | Klk13 | Fam13c |
Edn3 | Scn1b | Klk8 | Rhobtb1 |
Gm14391* | Gramd1a* | Klk7* | |
Gm6710 | Pdcd2l* | Klk1b9* | |
Zfp931 | Gpi1 | Klk1 | |
4931406P16Rik | Clec11a | ||
Kctd15 | Shank1 | ||
Chst8 | Syt3 | ||
Pepd | Lrrc4b | ||
Cebpa | Josd2 | ||
Slc7a10 | Spib | ||
Lrp3* | Pold1 | ||
Rhpn2 | Napsa* | ||
Faap24 | Kcnc3 | ||
Tdrd12* | Myh14 | ||
Ankrd27* | Atf5 | ||
Pdcd5 | Il4i1 | ||
Dpy19l3 | Pnkp* | ||
Tshz3* | Ptov1 | ||
Ccne1 | Fuz | ||
1600014C10Rik | Tsks | ||
Plekhf1 | Cpt1c* | ||
Vstm2b | |||
Zfp975* | |||
Zfp715* |
Discussion
Our broad profiling of both host and pathogen traits after Mtb infection in a large panel of CC strains, created a reproducible resource to study the diverse host-pathogen interactions that drive tuberculosis disease. The immunological analysis of the CC panel identified correlates of TB disease progression that were consistent with previous studies in both mice and human patients (Ahmed et al., 2020; Niazi et al., 2015; Zak et al., 2016). We also identified outlier strains that produce distinct immunological states, suggesting that our previous reliance on genetically homogenous lab strains of mice has oversimplified our understanding of TB pathogenesis. For example, despite the strong correlation between lung bacterial burden and weight loss, CC030/GeniUnc and CC040/TauUnc mice suffered from more inflammation and wasting than would be predicted from the number of bacteria in their lungs or spleens. This phenotype reflects a failure of disease ‘tolerance’, which is proposed to be a critical determinant of protective immunity (Ayres and Schneider, 2012; Olive et al., 2018). Similarly, we identified a number of CC genotypes that produce very low, or undetectable, levels of the protective cytokine IFNγ, but still control lung bacterial replication. While a growing body of literature suggests that immune responses distinct from the canonical Th1 response can control infection (Lu et al., 2019; Sakai et al., 2016), these CC strains are the first example of an animal model in which IFNγ appears to be dispensable. Despite the relatively small group sizes used in this initial phenotypic screen, the reproducibility of the CC strains facilitated the identification of these phenotypes and provides tractable models for further characterization.
The ability to separate aspects of the immune response from disease progression implied that these features are under distinct multigenic control. Our study demonstrated the feasibility of mapping the genetic variants that control the complex immune response to Mtb. The QTL identified in this study are generally distinct from CC loci that control immunity to viruses (Ferris et al., 2013; Gralinski et al., 2017; Noll et al., 2020) or another intracellular bacterial pathogen, Salmonella (Zhang et al., 2019). However, Tip8 and Tip10 overlap with QTL previously defined via Mtb infection of a CC001xCC042 F2 intercross population (Smith et al., 2019) suggesting that common variants may have been identified in both studies. While the specific genetic variants responsible for these QTL remain unknown, both coincident trait mapping and bioinformatic analysis suggest mechanistic explanations for some QTL-phenotype associations. For example, a single interval on chromosome two controls CFU levels and IL-10, and contains a variant in the Ctsz gene encoding Cathepsin Z. Ctsz is a strong candidate considering its known roles in autophagy (Amaral et al., 2018), dendritic cell differentiation and function (Obermajer et al., 2008), its upregulation in non-human primates (Ahmed et al., 2020) and human patients with Mtb (Zak et al., 2016), and the association of CTSZ variants with disease risk in human TB studies (Adams et al., 2011; Cooke et al., 2008). Regardless of the responsible variants, these data will facilitate the generation of new congenic animal models that isolate the contribution of each QTL to phenotype.
Using TnSeq as a multidimensional phenotyping method across this population provided insight into how the diversity of host-derived microenvironments have shaped the pathogen’s genome. While Mtb is an obligate pathogen with no significant environmental niche, only a minority of the genes in its genome have been found to contribute to bacterial fitness in either laboratory media or individual inbred mouse models, leaving the pressures that maintain the remaining genomic content unclear. Our study indicated that a roughly similar number of genes are important for Mtb fitness in a given mouse strain, even immunodeficient strains that likely represent the most divergent environments. While this observation may seem counterintuitive, it is consistent with previous TnSeq studies in both mouse models (Mishra et al., 2017) and in vitro conditions (Minato et al., 2019), where distinct but similarly sized gene sets are necessary for growth under very different conditions. Overall, we find that approximately three times more genes contribute to bacterial growth or survival in the CC population than in the standard B6 model. While some bacterial genetic requirements could be associated with known immune pathways, most of the differential pressures on bacterial mutants could not be attributed to these simple deficiencies in known mechanisms of immune control. Instead, it appears that the CC population produces a spectrum of novel environments, and that a relatively large fraction of the pathogen’s genome is needed to adapt to changing immune pressures. Differential pressures on these adaptive virulence functions are similarly apparent in genomic analyses of Mtb clinical isolates. Signatures of selection have been detected in ESX1-related genes (Holt et al., 2018; Sousa et al., 2020), phoPR (Gonzalo-Asensio et al., 2014), and the oxidative stress resistance gene sseA (de Keijzer et al., 2014), suggesting that Mtb is exposed to similarly variable host pressures in genetically diverse human and mouse populations. While the combinatorial complexity of associating host and pathogen genetic variants in natural populations is daunting, the identification of HipQTL in the CC panel indicates that these inter-species genetic interactions can be important determinants of pathogenesis and can be dissected using this tractable model of diversity.
Materials and methods
Key resources table.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus, male) | Collaborative Cross mice | DOI: https://doi.org/10.1038/ng1104-113 | ||
Strain, strain background (Mycobacterium tuberculosis) | H37Rv | DOI: 10.1073/pnas.2134250100 | ||
Genetic reagent (Mycobacterium tuberculosis) | ∆glpK; ∆pstC2; ∆eccB1; ∆mbtA; | DOI: 10.1128/mBio.01467–18 | ||
Genetic reagent (Mycobacterium tuberculosis) | ∆BioA | DOI: 10.1371/journal.ppat.1002264 | ||
Recombinant DNA reagent | pKM464 (plasmid) | DOI: 10.1128/mBio.01467–18 | ||
Recombinant DNA reagent | Barcode qtag (plasmid) | DOI: 10.1128/mSystems.00396–20 | ||
Sequence-based reagent | qtag/barcode sequencing primer sets | DOI: 10.1128/mSystems.00396–20 | Table S6 | |
Sequence-based reagent | MiniMUGA genotyping array | Neogen Inc | ||
Sequence-based reagent | GigaMUGA genotyping array | Neogen Inc | ||
Commercial assay or kit | 32-plex cytokine assay | Eve Technologies, Calgary, CA | ||
Software, algorithm | R/qtl2 | DOI: 10.1534/genetics.118.301595 | Dr. Karl Broman (University of Wisconsin-Madison) | |
Software, algorithm | WGCNA | DOI: 10.1186/1471-2105-9-559 | Dr. Peter Langfelder (UCLA) |
Mice
Male and female Collaborative Cross parental strains (A/J #0646; C57BL/6 J #0664; 129S1/SvImJ #02448; NOD/ShiLtJ #01976; NZO/HiLtJ #02105; CAST/EiJ #0928, PWK/PhJ #3,715 and WSB/EiJ #01145) and single gene immunological knockout mice were purchased from The Jackson Laboratory (Nos2-/- #2609, Cybb-/- #2365, Ifnγ-/- #2287) or Taconic (RagN12) and bred at UMASS. Male mice from 52 CC strains were purchased from the UNC Systems Genetics Core Facility (SGCF) between July 2013 and August 2014. The 52 CC strains used in this study include: CC001/Unc, CC002/Unc, CC003/Unc, CC004/TauUnc, CC005/TauUnc, CC006/TauUnc, CC007/Unc, CC008/GeniUnc, CC009/Unc, CC010/GeniUnc, CC011/Unc, CC012/GeniUnc, CC013/GeniUnc, CC015/Unc, CC016/GeniUnc, CC017/Unc, CC018/Unc, CC019/TauUnc, CC021/Unc, CC022/GeniUnc, CC023/GeniUnc, CC024/GeniUnc, CC025/GeniUnc, CC027/GeniUnc, CC028/GeniUnc, CC029/Unc, CC030/GeniUnc, CC031/GeniUnc, CC032/GeniUnc, CC033/GeniUnc, CC034/Unc, CC035/Unc, CC037/TauUnc, CC038/GeniUnc, CC039/Unc, CC040/TauUnc, CC041/TauUnc, CC042/GeniUnc, CC043/GeniUnc, CC044/Unc, CC045/GeniUnc, CC046/Unc, CC047/Unc, CC051/TauUnc, CC055/TauUnc, CC056/GeniUnc, CC057/Unc, CC059/TauUnc, CC060/Unc, CC061/GeniUnc, CC065/Unc, CC068/TauUnc. More information regarding the CC strains can be found at http://csbio.unc.edu/CCstatus/index.py?run=AvailableLines.information.
CC030 x CC029 F2 mice were generated in the FPMV lab at UNC by crossing CC030 and CC029 mice (purchased from the SGCF in 2016) to generate F1s (both CC030 dam by CC029 sires as well as CC029 dam by CC030 sires). The resulting F1s were subsequently intercrossed to generate 251 F2 mice with all possible grandparental combinations. Male and female F2 mice were shipped to UMASS for Mtb infections.
All mice were housed in a specific pathogen-free facility under standard conditions (12 hr light/dark, food and water ad libitum). Mice were infected with Mtb between 8 and 12 weeks of age. Male mice were used for initial large CC screen; male and female mice were used for F2 validation cohort.
M. tuberculosis trains
All M. tuberculosis strains (H37Rv background) were grown in Middlebrook 7H9 medium containing oleic acid-albumin-dextrose-catalase (OADC), 0.2% glycerol, and 0.05% Tween 80 to log-phase with shaking (200 rpm) at 37 °C. Hygromycin (50 µg/ml) or kanamycin (20 µg/ml) was added when necessary. The TnSeq library consisting of Himar1 transposon mutants was described previously (Sassetti et al., 2003). The ∆bioA strain was made by homologous recombination as previously described (Woong Park et al., 2011). For pooled mutant infections, deletion strains (GlpK, PstC2, EccB1, MbtA) were constructed using ORBIT (Murphy et al., 2018), which included gene replacement by the vector pKM464 carrying unique q-Tag sequences to identify each mutant for deep sequencing. The rnaseJ mutant was also made by ORBIT and was kindly provided by Dr. Nathan Hicks and Dr Sarah Fortune. Prior to all in vivo infections, cultures were washed, resuspended in phosphate-buffered saline (PBS) containing 0.05% Tween 80, and sonicated before diluting to desired concentration (see below).
Mouse infections
For TnSeq experiments, 1 × 106 CFU of a saturated library of Himar1 transposon mutants (Sassetti et al., 2003) was delivered via intravenous tail vein injection, resulting in an infectious dose (Day 1 CFU) of 105 in the spleen and 104 in the lung. For the TnSeq screen, groups of three to six mice per genotype were infected, including 52 CC strains, 8 parental strains, and single-gene knockout mice (Nos2-/-, Cybb-/-, Ifnγ-/- and RagN12). Mice were infected over three infection batches, as denoted in Figure 1—source data 1. Burden and immunological data from all surviving animals are provided in Figure 1—source data 1. At indicated time points mice were euthanized, and organs were harvested then homogenized in a FastPrep-24 (MP Biomedicals). CFU was determined by dilution plating on 7H10 agar with 20 µg/mL kanamycin. For library recovery, approximately 1 × 106 CFU per mouse was plated on 7H10 agar with 20 µg/mL kanamycin. After three weeks of growth, colonies were harvested by scraping and genomic DNA was extracted. The relative abundance of each transposon mutant was estimated as described (Long et al., 2015).
Single strain validation aerosol infections were performed in a Glas-Col machine to deliver 50–150 CFU/mouse. At indicated time points, mice were euthanized, and organs were harvested then homogenized in a FastPrep-24 (MP Biomedicals). CFU was determined by dilution plating on 7H10 agar with 20 ug/mL kanamycin or 50 µg/mL hygromycin as required.
Chromosomal equivalent (CEQ) was enumerated according to previously published protocol (Lin et al., 2014; Munoz-Elías et al., 2005). Cytokines and chemokines were assayed from organ homogenates using the pro-inflammatory focused 32-plex (Eve Technologies, Calgary, CA).
For pooled mutant infections, three to five mice per genotype (B6, CC051, PWK, CC042, CC005, CC018) were infected with a pool of deletion mutants at equal ratios via the intravenous route (1 × 106 CFU/mouse resulting in an infectious dose (D1 CFU) of 1 × 105 in the spleen). At indicated time points, approximately 10,000 CFU from the spleen homogenate of each mouse was plated on 7H10 agar. Genomic DNA was extracted for sequencing as described previously (Long et al., 2015). Sequencing libraries spanning the variable region of each q-Tag were generated using PCR primers binding to regions common among all q-Tags, similar to previously described protocols (Bellerose et al., 2020; Blumenthal et al., 2010; Martin et al., 2017). In each PCR, a unique molecular counter was incorporated into the sequence to allow for the accurate counting of input templates and account for PCR jackpotting. The libraries were sequenced to 1000-fold coverage on an Illumina NextSeq platform using a 150-cycle Mid-Output kit with single-end reads. Total abundance of each mutant in the library was determined by counting the number of reads for each q-Tag with a unique molecular counter. Relative abundance of each mutant in the pool was then calculated by dividing the total abundance of a mutant by the total abundance of reads for wild-type H37Rv. The relative abundance was normalized to relative abundance at initial infection (Day 0) and log2 transformed. Fitness was calculated as previously described (Palace et al., 2014). Burden and normalized counts from all Mtb mutants in each mouse are provided in Figure 4—source data 2.
For CC030 x CC029 F2 infections, 251 F2 mice (including equivalent numbers of male and female mice) were infected via IV route with an infectious dose of 105 CFU of TnSeq library (as described above), to replicate the original CC infection experimental conditions. Mice were sacrificed at 1 month post-infection and bacterial burden was quantified by plating for CFU (as described above).
Quantification and statistical analysis
TnSeq analysis
TnSeq libraries were prepared and counts of each transposon mutant were estimated as described (Long et al., 2015). NCBI Reference Sequence NC_018143.1 was used for H37Rv genome and annotations. A total of 123 libraries were sequenced, capturing 60 distinct mouse genotypes. In the majority of cases, two replicate mouse libraries were used per genotype. Only a single TnSeq library was obtained for CC010, CC031, CC037, CC059, CC016, and PWK/PhJ. Insertion mutant counts across all libraries were normalized by beta-geometric correction (DeJesus et al., 2015), binned by gene, and replicate values for each mouse genotype averaged. Mean values for each gene were divided by the grand mean then log2 transformed and quantile normalized. The resulting phenotype values were used for both WGCNA and QTL mapping.
To eliminate genes having no meaningful variation across the mouse panel, statistical tests of log2 fold change (LFC) in counts between all possible pairs of mouse genotypes were performed by resampling (DeJesus et al., 2015). 679 ‘significantly varying genes’ were identified whose representation varied significantly (FDR < 5%) in at least two independent comparisons. For relative mutant abundance estimates, LF C in counts between in vitro-grown H37Rv (six replicate libraries) vs libraries from each mouse genotype were determined by resampling as above. LFC, Q-values and modules for TnSeq data across the mouse strains is available in Figure 4—source data 1.
WGCNA analysis
Weighted gene correlation network analysis (WGCNA) was applied to categorize the 679 significantly varying genes into 20 internally-correlated modules (Langfelder and Horvath, 2008). Modules were filtered (intramodular connectivity >0.6) to obtain the most representative genes. First principal component scores of module eigengenes were used as phenotype values for QTL mapping after first winsorizing (q = 0.05) using the R package broman (https://cran.r-project.org/web/packages/broman/index.html).
In order to perform association analysis between modules of genes and clusters of mice (Figure 5B), the mice were clustered based on the matrix of TnSeq LFCs for significantly varying genes using hclust in R (with the ‘Ward.D2’ distance metric). Then, for each module of genes, the LFCs in each cluster of mice were pooled and compared to all the other mice using a t-test, identifying modules with a mean LFC in a specific mouse cluster that is significantly higher or lower than the average across all the other mice. The resulting p-values over all combinations of gene modules and mouse clusters were adjusted using Benjamini-Hochberg for an overall FDR < 0.05.
Disease-related trait analysis and heritability estimation
For the trait heatmap, trait values were clustered (hclust in R package heatmaply; traits scaled as per default function) and dendrogram nodes colored by 3 k-means. Correlation between disease-related TB traits for both IV and aerosol validation experiments was determined by Pearson’s correlation and visualized using corrplot (ordered by hclust) (Figure 1—figure supplements 1 and 2). Heritability (h2) of the immunological and TB disease-related traits was calculated by estimating the percent of variation attributed to between strain differences relative to within strain noise as previously described (Appendix1) (Noll et al., 2020). This is explicitly: SS(strain)/SS(total) in an ANOVA table (where SS(total) is SS(strain)+ SS(error)) (SS; sum of squares). p-Values were calculated by ANOVA and multiple-test corrected using the Benjamini-Hochberg method. Throughout the text, correlations are cited using the following standardized nomenclature: 0–0.19 = very weak, 0.2–0.39 = weak, 0.40–0.59 = moderate, 0.6–0.79 = strong, 0.8–1.0 = very strong correlation.
Genotyping and QTL mapping
A subset of the inbred CC mice used in the analysis were genotyped on the GigaMUGA array (Morgan et al., 2015) available from Neogen Inc The inbred parents, F1s and F2 mice from the CC030xCC029 cross were genotyped on the MiniMUGA array (Sigmon et al., 2020) at Neogen Inc, For CC030 x CC029 F2 QTL analysis, markers were filtered to 2499 markers that differentiated between CC029 and CC030 haplotypes (Figure 3—source data 1). For QTL mapping in the F2 panel, genotype (Figure 3—source data 1) and lung burden data (Figure 3—source data 2) from 251 Mtb-infected F2 individuals was imported into R (version 3.6.1) and formatted for R/qtl2 (version 0.20) (Broman et al., 2019). QTL mapping incorporated kinship as a covariate using the LOCO (Leave One Chromosome Out) method. Further, sex and infection batch were also considered as covariates for mapping. LOD scores were calculated within R/qtl2 to assess genotypic associations with lung burden at each marker. QTL significance thresholds were established by 10,000 permutations.
For QTL mapping in the CC panel, the Most Recent Common Ancestor (Srivastava et al., 2017) 36-state haplotypes were downloaded from the UNC Systems Genetics Core Facility and simplified to 8-state haplotype probabilities (for the 8 CC founder strains), which is appropriate for additive genetic mapping. We generated 36-state haplotype probabilities from the individual CC mice genotyped on GigaMUGA and combined these data with the MRCA data to obtain a common genome cache.
For CC QTL analysis, genotype and phenotype data were imported into R (version 3.6.1) and reformatted for R/qtl2 (version 0.20) (Broman et al., 2019). Individual TnSeq and clinical trait phenotype values were winsorized (q = 0.006) as above. GigaMUGA annotations were downloaded from the Jackson Laboratory, and markers were thinned to a spacing of 0.1 cM using the reduce_markers function of R/qtl2. The final genetic map contained 10,067 markers. QTL mapping was carried out using a linear mixed model with LOCO (leave one chromosome out) kinship. For clinical trait scans, batch (denoted by ‘block’ in Figure 1—source data 1) was included as an additive covariate. Significance thresholds for QTL were estimated using 10,000 permutations (scan1_perm function). For each trait, the maximum LOD scores from the permutation scans were used to fit generalized extreme value distributions, from which genome-wide permutation p-values were calculated. LOD profiles and effect plots were generated using the plotting functions of the R/qtl2 package. Multiple QTL at similar genetic locations were assessed for independence using qtl2pleio with 400 bootstrap samples (Boehm et al., 2019). The quantile-based permutation thresholding method of Neto et al., 2012 was used to assess the statistical significance of co-mapping traits. The NL-method, which determines the LOD thresholds controlling genome-wide error rate for a given p-value and ‘hotspot’ size, was employed.
Candidate gene prioritization
To identify potential candidate genes, we focused on three QTL that were either statistically significant (Tip5, Hip42) or were validated by intercross (Tip8). For each QTL interval (determined by Bayesian interval in qtl2), we identified mouse genes that were in differentially expressed modules between infected lungs of resistant and susceptible mouse strains (Moreira-Teixeira et al., 2020). Of these genes, we next used the Sanger sequence data (Keane et al., 2011) to filter on genetic variants segregating between CC founder haplotypes. Where there were clear causal haplotypes, we further filtered to genes with missense or nonsense variants.
Acknowledgements
We thank all members of Sassetti Lab, past and present for technical help and discussions; Dr. Nathan Hicks and Dr. Sarah Fortune for kindly providing the rnaseJ mutant; Dr. David Tobin for insightful manuscript comments; Dr. Dennis Ko for QTL acronym creativity; and the Systems Genetic Core at UNC for their help in procuring CC mice in timely fashion. This work was supported by NIH grants AI132130 to C M Sassetti and FPMV; U19AI100625 to FPMV and MF; a fellowship from the Charles H King Foundation to C M Smith; and a HHMI Gilliam Fellowship A20-0146 to BKH. The genetic characterization of the CC strains was supported in part by NIH grant U24HG010100 to FPMV.
Appendix 1
Appendix 1—table 1. Heritability (h2) estimates for each measured TB-disease associated phenotype (Tuberculosis ImmunoPhenotypes;Tip).
Trait | h2 (%) | p-value | Adj. p-value |
---|---|---|---|
IFN-γ | 87.70 | 7.90E-20 | 2.21E-18 |
Lung CFU | 83.30 | 5.83E-15 | 8.16E-14 |
Lung CEQ | 80.55 | 2.65E-14 | 2.47E-13 |
CXCL1 | 81.57 | 8.19E-14 | 5.73E-13 |
MIG | 81.19 | 1.62E-13 | 9.09E-13 |
MIP-2 | 80.82 | 3.07E-13 | 1.43E-12 |
IP-10 | 80.13 | 9.73E-13 | 3.89E-12 |
M-CSF | 79.33 | 3.54E-12 | 1.24E-11 |
IL-17 | 78.85 | 7.43E-12 | 2.31E-11 |
MIP-1α | 78.02 | 2.53E-11 | 7.08E-11 |
G-CSF | 77.71 | 3.98E-11 | 1.01E-10 |
MCP-1 | 77.05 | 1.00E-10 | 2.34E-10 |
IL-1α | 75.62 | 6.60E-10 | 1.42E-09 |
IL-6 | 73.97 | 4.89E-09 | 9.77E-09 |
RANTES | 73.70 | 6.63E-09 | 1.20E-08 |
Spleen CFU | 72.94 | 6.83E-09 | 1.20E-08 |
LIF | 73.48 | 8.50E-09 | 1.40E-08 |
VEGF | 73.08 | 1.34E-08 | 2.08E-08 |
IL-1β | 71.66 | 6.11E-08 | 9.00E-08 |
Weight Change | 67.56 | 8.75E-07 | 1.22E-06 |
MIP-1β | 68.51 | 1.23E-06 | 1.65E-06 |
TNF-α | 66.38 | 7.39E-06 | 9.41E-06 |
LIX | 65.30 | 1.70E-05 | 2.07E-05 |
Eotaxin | 64.27 | 3.63E-05 | 4.23E-05 |
IL-10 | 63.97 | 4.48E-05 | 5.02E-05 |
IL-2 | 62.87 | 9.59E-05 | 1.03E-04 |
Spleen CEQ | 60.43 | 1.09E-04 | 1.13E-04 |
IL-9 | 56.79 | 3.19E-03 | 3.19E-03 |
Funding Statement
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Contributor Information
Clare M Smith, Email: clare.m.smith@duke.edu.
Christopher M Sassetti, Email: christopher.sassetti@umassmed.edu.
Bavesh D Kana, University of the Witwatersrand, South Africa.
Bavesh D Kana, University of the Witwatersrand, South Africa.
Funding Information
This paper was supported by the following grants:
National Institute of Allergy and Infectious Diseases AI132130 to Fernando Pardo-Manuel de Villena, Christopher M Sassetti.
National Institute of Allergy and Infectious Diseases U19AI100625 to Fernando Pardo-Manuel de Villena, Martin T Ferris.
Howard Hughes Medical Institute A20-0146 to Brea K Hampton.
National Human Genome Research Institute U24HG010100 to Fernando Pardo-Manuel de Villena.
Bank of America Charles H King Postdoctoral Fellowship to Clare M Smith.
Additional information
Competing interests
No competing interests declared.
No competing interests declared.
Author contributions
Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft.
Data curation, Formal analysis, Methodology, Visualization, Writing – original draft.
Formal analysis, Investigation, Validation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Validation, Writing – review and editing.
Investigation, Validation, Writing – review and editing.
Investigation, Validation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Methodology, Validation, Writing – review and editing.
Supervision, Validation, Writing – review and editing.
Investigation, Methodology, Writing – review and editing.
Investigation, Writing – review and editing.
Methodology, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Investigation, Writing – review and editing.
Supervision, Validation, Writing – review and editing.
Supervision, Validation, Writing – review and editing.
Funding acquisition, Resources, Supervision, Writing – review and editing.
Funding acquisition, Investigation, Methodology, Supervision, Writing – review and editing.
Investigation, Methodology, Resources, Supervision, Writing – original draft.
Conceptualization, Formal analysis, Funding acquisition, Project administration, Supervision, Writing – original draft.
Ethics
Mouse studies were performed in strict accordance using the recommendations from the Guide for the Care and Use of Laboratory Animals of the National Institute of Health and the Office of Laboratory Animal Welfare. Mouse studies at the University of Massachusetts Medical School (UMASS) were performed using protocols approved by the UMASS Institutional Animal Care and Use Committee (IACUC) (Animal Welfare Assurance Number A3306-01) in a manner designed to minimize pain and suffering in Mtb-infected animals. Any animal that exhibited severe disease signs was immediately euthanized in accordance with IACUC approved endpoints. All mouse studies at UNC (Animal Welfare Assurance #A3410-01) were performed using protocols approved by the UNC Institutional Animal Care and Use Committee (IACUC).
Additional files
Data availability
All relevant data to support the findings of this study are located within the paper and supplementary files. Genome sequence data is deposited in the NCBI Gene Expression Omnibus (GEO), accession number GSE164156. All raw phenotype values and QTL mapping objects are located on GitHub @sassettilab in the https://github.com/sassettilab/Smith_et_al_CC_TnSeq, (copy archived at swh:1:rev:2ded9735b23d9780eb7872eb55625cff35090430) repository.
The following dataset was generated:
Smith CM. 2021. Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice. NCBI Gene Expression Omnibus. GSE164156
References
- Abel L, Fellay J, Haas DW, Schurr E, Srikrishna G, Urbanowski M, Chaturvedi N, Srinivasan S, Johnson DH, Bishai WR. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. The Lancet. Infectious Diseases. 2018;18:e64–e75. doi: 10.1016/S1473-3099(17)30623-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adams LA, Möller M, Nebel A, Schreiber S, van der Merwe L, van Helden PD, Hoal EG. Polymorphisms in MC3R promoter and CTSZ 3’UTR are associated with tuberculosis susceptibility. European Journal of Human Genetics. 2011;19:676–681. doi: 10.1038/ejhg.2011.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed M, Thirunavukkarasu S, Rosa BA, Thomas KA, Das S, Rangel-Moreno J, Lu L, Mehra S, Mbandi SK, Thackray LB, Diamond MS, Murphy KM, Means T, Martin J, Kaushal D, Scriba TJ, Mitreva M, Khader SA. Immune correlates of tuberculosis disease and risk translate across species. Science Translational Medicine. 2020;12:eaay0233. doi: 10.1126/scitranslmed.aay0233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Döffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (New York, N.Y.) 1998;280:1432–1435. doi: 10.1126/science.280.5368.1432. [DOI] [PubMed] [Google Scholar]
- Amaral EP, Riteau N, Moayeri M, Maier N, Mayer-Barber KD, Pereira RM, Lage SL, Kubler A, Bishai WR, D’Império-Lima MR, Sher A, Andrade BB. Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages. Frontiers in Immunology. 2018;9:1427. doi: 10.3389/fimmu.2018.01427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ansari MA, Pedergnana V, L C Ip C, Magri A, Von Delft A, Bonsall D, Chaturvedi N, Bartha I, Smith D, Nicholson G, McVean G, Trebes A, Piazza P, Fellay J, Cooke G, Foster GR, Hudson E, McLauchlan J, Simmonds P, Bowden R, Klenerman P, Barnes E, Spencer CCA, STOP-HCV Consortium Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nature Genetics. 2017;49:666–673. doi: 10.1038/ng.3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB, Gralinski LE, Bell TA, Didion JD, Hua K, Nehrenberg DL, Powell CL, Steigerwalt J, Xie Y, Kelada SNP, Collins FS, Yang IV, Schwartz DA, Branstetter LA, Chesler EJ, Miller DR, Spence J, Liu EY, McMillan L, Sarkar A, Wang J, Wang W, Zhang Q, Broman KW, Korstanje R, Durrant C, Mott R, Iraqi FA, Pomp D, Threadgill D, de Villena FP-M, Churchill GA. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Research. 2011;21:1213–1222. doi: 10.1101/gr.111310.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ayres JS, Schneider DS. Tolerance of infections. Annual Review of Immunology. 2012;30:271–294. doi: 10.1146/annurev-immunol-020711-075030. [DOI] [PubMed] [Google Scholar]
- Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition. The Journal of Immunology. 2011;186:1598–1607. doi: 10.4049/jimmunol.1003304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bellerose MM, Baek SH, Huang CC, Moss CE, Koh EI, Proulx MK, Smith CM, Baker RE, Lee JS, Eum S, Shin SJ, Cho SN, Murray M, Sassetti CM, Heran Darwin K, Waldor M, Russell D. Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy. MBio. 2019;10:e00663. doi: 10.1128/mBio.00663-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bellerose MM, Proulx MK, Smith CM, Baker RE, Ioerger TR, Sassetti CM, Marshall CW. Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis. MSystems. 2020;5:mSystems.00396-20. doi: 10.1128/mSystems.00396-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, Engstrand L, Enroth H, Burette A, Megraud F, Varon C, Atherton JC, Smith S, Wilkinson TS, Hitchings MD, Falush D, Sheppard SK. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk. BMC Biology. 2018;16:84. doi: 10.1186/s12915-018-0550-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blumenthal A, Trujillo C, Ehrt S, Schnappinger D. Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLOS ONE. 2010;5:e15667. doi: 10.1371/journal.pone.0015667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boehm FJ, Chesler EJ, Yandell BS, Broman KW. Testing Pleiotropy vs. Separate QTL in Multiparental Populations. G3: Genes, Genomes, Genetics. 2019;9:2317–2324. doi: 10.1534/g3.119.400098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong X-F, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova J-L. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science (New York, N.Y.) 2012;337:1684–1688. doi: 10.1126/science.1224026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broman KW, Gatti DM, Simecek P, Furlotte NA, Prins P, Sen Ś, Yandell BS, Churchill GA. R/qtl2: Software for Mapping Quantitative Trait Loci with High-Dimensional Data and Multiparent Populations. Genetics. 2019;211:495–502. doi: 10.1534/genetics.118.301595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Seminars in Immunology. 2014;26:454–470. doi: 10.1016/j.smim.2014.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. Journal of Immunology (Baltimore, Md. 1999;162:5407–5416. [PubMed] [Google Scholar]
- Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NTN, Thuong NTT, Stepniewska K, Huyen MNT, Bang ND, Loc TH, Gagneux S, van Soolingen D, Kremer K, van der Sande M, Small P, Anh PTH, Chinh NT, Quy HT, Duyen NTH, Tho DQ, Hieu NT, Torok E, Hien TT, Dung NH, Nhu NTQ, Duy PM, van Vinh Chau N, Farrar J. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLOS Pathogens. 2008;4:e1000034. doi: 10.1371/journal.ppat.1000034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen L, Xie QW, Nathan C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Molecular Cell. 1998;1:795–805. doi: 10.1016/s1097-2765(00)80079-9. [DOI] [PubMed] [Google Scholar]
- Churchill G.A., Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963–971. doi: 10.1093/genetics/138.3.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, Bleich A, Bogue M, Broman KW, Buck KJ, Buckler E, Burmeister M, Chesler EJ, Cheverud JM, Clapcote S, Cook MN, Cox RD, Crabbe JC, Crusio WE, Darvasi A, Deschepper CF, Doerge RW, Farber CR, Forejt J, Gaile D, Garlow SJ, Geiger H, Gershenfeld H, Gordon T, Gu J, Gu W, de Haan G, Hayes NL, Heller C, Himmelbauer H, Hitzemann R, Hunter K, Hsu H-C, Iraqi FA, Ivandic B, Jacob HJ, Jansen RC, Jepsen KJ, Johnson DK, Johnson TE, Kempermann G, Kendziorski C, Kotb M, Kooy RF, Llamas B, Lammert F, Lassalle J-M, Lowenstein PR, Lu L, Lusis A, Manly KF, Marcucio R, Matthews D, Medrano JF, Miller DR, Mittleman G, Mock BA, Mogil JS, Montagutelli X, Morahan G, Morris DG, Mott R, Nadeau JH, Nagase H, Nowakowski RS, O’Hara BF, Osadchuk AV, Page GP, Paigen B, Paigen K, Palmer AA, Pan H-J, Peltonen-Palotie L, Peirce J, Pomp D, Pravenec M, Prows DR, Qi Z, Reeves RH, Roder J, Rosen GD, Schadt EE, Schalkwyk LC, Seltzer Z, Shimomura K, Shou S, Sillanpää MJ, Siracusa LD, Snoeck H-W, Spearow JL, Svenson K, Tarantino LM, Threadgill D, Toth LA, Valdar W, de Villena FP-M, Warden C, Whatley S, Williams RW, Wiltshire T, Yi N, Zhang D, Zhang M, Zou F, Complex Trait Consortium The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nature Genetics. 2004;36:1133–1137. doi: 10.1038/ng1104-1133. [DOI] [PubMed] [Google Scholar]
- Churchill GA, Gatti DM, Munger SC, Svenson KL. The Diversity Outbred mouse population. Mammalian Genome. 2012;23:713–718. doi: 10.1007/s00335-012-9414-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. The American Review of Respiratory Disease. 1978;117:621–624. doi: 10.1164/arrd.1978.117.4.621. [DOI] [PubMed] [Google Scholar]
- Cooke GS, Campbell SJ, Bennett S, Lienhardt C, McAdam KPWJ, Sirugo G, Sow O, Gustafson P, Mwangulu F, van Helden P, Fine P, Hoal EG, Hill AVS. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2008;178:203–207. doi: 10.1164/rccm.200710-1554OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of Experimental Medicine. 1993;178:2243–2247. doi: 10.1084/jem.178.6.2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. The Journal of Experimental Medicine. 1997;186:39–45. doi: 10.1084/jem.186.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Keijzer J, de Haas PE, van Veelen PA, van Soolingen D. Disclosure of selective advantages in the “modern” sublineage of the Mycobacterium tuberculosis Beijing genotype family by quantitative proteomics. Molecular & Cellular Proteomics: MCP. 2014;13:2632–2645. doi: 10.1074/mcp.M114.038380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeJesus MA, Ambadipudi C, Baker R, Sassetti C, Ioerger TR. TRANSIT--A Software Tool for Himar1 TnSeq Analysis. PLOS Computational Biology. 2015;11:e1004401. doi: 10.1371/journal.pcbi.1004401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dick T, Manjunatha U, Kappes B, Gengenbacher M. Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis. Molecular Microbiology. 2010;78:980–988. doi: 10.1111/j.1365-2958.2010.07381.x. [DOI] [PubMed] [Google Scholar]
- Ferris MT, Aylor DL, Bottomly D, Whitmore AC, Aicher LD, Bell TA, Bradel-Tretheway B, Bryan JT, Buus RJ, Gralinski LE, Haagmans BL, McMillan L, Miller DR, Rosenzweig E, Valdar W, Wang J, Churchill GA, Threadgill DW, McWeeney SK, Katze MG, Pardo-Manuel de Villena F, Baric RS, Heise MT. Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. PLOS Pathogens. 2013;9:e1003196. doi: 10.1371/journal.ppat.1003196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku C-L, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, Feinberg J, Durandy A, Senechal B, Chapgier A, Vogt G, de Beaucoudrey L, Fieschi C, Picard C, Garfa M, Chemli J, Bejaoui M, Tsolia MN, Kutukculer N, Plebani A, Notarangelo L, Bodemer C, Geissmann F, Israël A, Véron M, Knackstedt M, Barbouche R, Abel L, Magdorf K, Gendrel D, Agou F, Holland SM, Casanova J-L. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. The Journal of Experimental Medicine. 2006;203:1745–1759. doi: 10.1084/jem.20060085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. The Journal of Experimental Medicine. 1993;178:2249–2254. doi: 10.1084/jem.178.6.2249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM. Variable host-pathogen compatibility in Mycobacterium tuberculosis. PNAS. 2006;103:2869–2873. doi: 10.1073/pnas.0511240103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infection and Immunity. 2004;72:1733–1745. doi: 10.1128/IAI.72.3.1733-1745.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goitre L, Trapani E, Trabalzini L, Retta SF. The Ras superfamily of small GTPases: the unlocked secrets. Methods in Molecular Biology (Clifton, N.J.) 2014;1120:1–18. doi: 10.1007/978-1-62703-791-4_1. [DOI] [PubMed] [Google Scholar]
- Gonzalo-Asensio J, Malaga W, Pawlik A, Astarie-Dequeker C, Passemar C, Moreau F, Laval F, Daffé M, Martin C, Brosch R, Guilhot C. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. PNAS. 2014;111:11491–11496. doi: 10.1073/pnas.1406693111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gopal R., Lin Y, Obermajer N, Slight S, Nuthalapati N, Ahmed M, Kalinski P, Khader SA. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. European Journal of Immunology. 2012;42:364–373. doi: 10.1002/eji.201141569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gopal R, Monin L, Torres D, Slight S, Mehra S, McKenna KC, Fallert Junecko BA, Reinhart TA, Kolls J, Báez-Saldaña R, Cruz-Lagunas A, Rodríguez-Reyna TS, Kumar NP, Tessier P, Roth J, Selman M, Becerril-Villanueva E, Baquera-Heredia J, Cumming B, Kasprowicz VO, Steyn AJC, Babu S, Kaushal D, Zúñiga J, Vogl T, Rangel-Moreno J, Khader SA. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2013;188:1137–1146. doi: 10.1164/rccm.201304-0803OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gralinski LE, Menachery VD, Morgan AP, Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC, Schäfer A, Pardo-Manuel de Villena F, Ferris MT, Baric RS. Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice. G3: Genes, Genomes, Genetics. 2017;7:1653–1663. doi: 10.1534/g3.117.041434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW, Gagneux S. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLOS Biology. 2008;6:e311. doi: 10.1371/journal.pbio.0060311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hillas PJ, del Alba FS, Oyarzabal J, Wilks A, Ortiz De Montellano PR. The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis. The Journal of Biological Chemistry. 2000;275:18801–18809. doi: 10.1074/jbc.M001001200. [DOI] [PubMed] [Google Scholar]
- Holt KE, McAdam P, Thai PVK, Thuong NTT, Ha DTM, Lan NN, Lan NH, Nhu NTQ, Hai HT, Ha VTN, Thwaites G, Edwards DJ, Nath AP, Pham K, Ascher DB, Farrar J, Khor CC, Teo YY, Inouye M, Caws M, Dunstan SJ. Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam. Nature Genetics. 2018;50:849–856. doi: 10.1038/s41588-018-0117-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, Heger A, Agam A, Slater G, Goodson M, Furlotte NA, Eskin E, Nellåker C, Whitley H, Cleak J, Janowitz D, Hernandez-Pliego P, Edwards A, Belgard TG, Oliver PL, McIntyre RE, Bhomra A, Nicod J, Gan X, Yuan W, van der Weyden L, Steward CA, Bala S, Stalker J, Mott R, Durbin R, Jackson IJ, Czechanski A, Guerra-Assunção JA, Donahue LR, Reinholdt LG, Payseur BA, Ponting CP, Birney E, Flint J, Adams DJ. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477:289–294. doi: 10.1038/nature10413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keller MP, Gatti DM, Schueler KL, Rabaglia ME, Stapleton DS, Simecek P, Vincent M, Allen S, Broman AT, Bacher R, Kendziorski C, Broman KW, Yandell BS, Churchill GA, Attie AD. Genetic Drivers of Pancreatic Islet Function. Genetics. 2018;209:335–356. doi: 10.1534/genetics.118.300864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology. 2007;8:369–377. doi: 10.1038/ni1449. [DOI] [PubMed] [Google Scholar]
- Koyuncu D, Niazi MKK, Tavolara T, Abeijon C, Ginese ML, Liao Y, Mark C, Specht A, Gower AC, Restrepo BI, Gatti DM, Kramnik I, Gurcan M, Yener B, Beamer G. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. PLOS Pathogens. 2021;17:e1009773. doi: 10.1371/journal.ppat.1009773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. doi: 10.1186/1471-2105-9-559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lazar-Molnar E, Chen B, Sweeney KA, Wang EJ, Liu W, Lin J, Porcelli SA, Almo SC, Nathenson SG, Jacobs WR. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. PNAS. 2010;107:13402–13407. doi: 10.1073/pnas.1007394107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Le Chevalier F, Cascioferro A, Frigui W, Pawlik A, Boritsch EC, Bottai D, Majlessi L, Herrmann JL, Brosch R. Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis. Scientific Reports. 2015;5:16918. doi: 10.1038/srep16918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nature Medicine. 2014;20:75–79. doi: 10.1038/nm.3412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Long JE, DeJesus M, Ward D, Baker RE, Ioerger T, Sassetti CM. Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods in Molecular Biology (Clifton, N.J.) 2015;1279:79–95. doi: 10.1007/978-1-4939-2398-4_6. [DOI] [PubMed] [Google Scholar]
- Long M, Kranjc T, Mysior MM, Simpson JC. RNA Interference Screening Identifies Novel Roles for RhoBTB1 and RhoBTB3 in Membrane Trafficking Events in Mammalian Cells. Cells. 2020;9:E1089. doi: 10.3390/cells9051089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G. IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure. Nature Medicine. 2019;25:977–987. doi: 10.1038/s41591-019-0441-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin CJ, Cadena AM, Leung VW, Lin PL, Maiello P, Hicks N, Chase MR, Flynn JL, Fortune SM. Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis. MBio. 2017;8:e00312-17. doi: 10.1128/mBio.00312-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McHenry ML, Williams SM, Stein CM. Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches. Infection, Genetics and Evolution. 2020;81:104204. doi: 10.1016/j.meegid.2020.104204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minato Y, Gohl DM, Thiede JM, Chacón JM, Harcombe WR, Maruyama F, Baughn AD. Genomewide Assessment of Mycobacterium tuberculosis Conditionally Essential Metabolic Pathways. MSystems. 2019;4:mSystems.00070-19. doi: 10.1128/mSystems.00070-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minch KJ, Rustad TR, Peterson EJR, Winkler J, Reiss DJ, Ma S, Hickey M, Brabant W, Morrison B, Turkarslan S, Mawhinney C, Galagan JE, Price ND, Baliga NS, Sherman DR. The DNA-binding network of Mycobacterium tuberculosis. Nature Communications. 2015;6:5829. doi: 10.1038/ncomms6829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishra BB, Rathinam VAK, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA, Sassetti CM. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nature Immunology. 2013;14:52–60. doi: 10.1038/ni.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishra BB, Lovewell RR, Olive AJ, Zhang G, Wang W, Eugenin E, Smith CM, Phuah JY, Long JE, Dubuke ML, Palace SG, Goguen JD, Baker RE, Nambi S, Mishra R, Booty MG, Baer CE, Shaffer SA, Dartois V, McCormick BA, Chen X, Sassetti CM. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nature Microbiology. 2017;2:17072. doi: 10.1038/nmicrobiol.2017.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moreira-Teixeira L, Tabone O, Graham CM, Singhania A, Stavropoulos E, Redford PS, Chakravarty P, Priestnall SL, Suarez-Bonnet A, Herbert E, Mayer-Barber KD, Sher A, Fonseca KL, Sousa J, Cá B, Verma R, Haldar P, Saraiva M, O’Garra A. Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis. Nature Immunology. 2020;21:464–476. doi: 10.1038/s41590-020-0610-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morgan AP, Fu CP, Kao CY, Welsh CE, Didion JP, Yadgary L, Hyacinth L, Ferris MT, Bell TA, Miller DR, Giusti-Rodriguez P, Nonneman RJ, Cook KD, Whitmire JK, Gralinski LE, Keller M, Attie AD, Churchill GA, Petkov P, Sullivan PF, Brennan JR, McMillan L, Pardo-Manuel de Villena F. The Mouse Universal Genotyping Array: From Substrains to Subspecies. G3: Genes, Genomes, Genetics. 2015;6:263–279. doi: 10.1534/g3.115.022087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morth JP, Gosmann S, Nowak E, Tucker PA. A novel two-component system found in Mycobacterium tuberculosis. FEBS Letters. 2005;579:4145–4148. doi: 10.1016/j.febslet.2005.06.043. [DOI] [PubMed] [Google Scholar]
- Munoz-Elías EJ, Timm J, Botha T, Chan WT, Gomez JE, McKinney JD. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infection and Immunity. 2005;73:546–551. doi: 10.1128/IAI.73.1.546-551.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy KC, Nelson SJ, Nambi S, Papavinasasundaram K, Baer CE, Sassetti CM. ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes. MBio. 2018;9:mBio.01467-18. doi: 10.1128/mBio.01467-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nambi S, Long JE, Mishra BB, Baker R, Murphy KC, Olive AJ, Nguyen HP, Shaffer SA, Sassetti CM. The Oxidative Stress Network of Mycobacterium tuberculosis Reveals Coordination between Radical Detoxification Systems. Cell Host & Microbe. 2015;17:829–837. doi: 10.1016/j.chom.2015.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neto EC, Keller MP, Broman AF, Attie AD, Jansen RC, Broman KW, Yandell BS. Quantile-based permutation thresholds for quantitative trait loci hotspots. Genetics. 2012;191:1355–1365. doi: 10.1534/genetics.112.139451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niazi MKK, Dhulekar N, Schmidt D, Major S, Cooper R, Abeijon C, Gatti DM, Kramnik I, Yener B, Gurcan M, Beamer G. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice. Disease Models & Mechanisms. 2015;8:1141–1153. doi: 10.1242/dmm.020867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noll KE, Ferris MT, Heise MT. The Collaborative Cross: A Systems Genetics Resource for Studying Host-Pathogen Interactions. Cell Host & Microbe. 2019;25:484–498. doi: 10.1016/j.chom.2019.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noll KE, Whitmore AC, West A, McCarthy MK, Morrison CR, Plante KS, Hampton BK, Kollmus H, Pilzner C, Leist SR, Gralinski LE, Menachery VD, Schäfer A, Miller D, Shaw G, Mooney M, McWeeney S, Pardo-Manuel de Villena F, Schughart K, Morrison TE, Baric RS, Ferris MT, Heise MT. Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross. Cell Reports. 2020;31:107587. doi: 10.1016/j.celrep.2020.107587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. Journal of Leukocyte Biology. 2008;84:1306–1315. doi: 10.1189/jlb.0508285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olive AJ, Smith CM, Kiritsy MC, Sassetti CM. The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection. Journal of Immunology (Baltimore, Md. 2018;201:1705–1716. doi: 10.4049/jimmunol.1800202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palace SG, Proulx MK, Lu S, Baker RE, Goguen JD. Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis in deep tissue. MBio. 2014;5:mBio.01385-14. doi: 10.1128/mBio.01385-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. PNAS. 2008;105:4376–4380. doi: 10.1073/pnas.0711159105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pethe K, Sequeira PC, Agarwalla S, Rhee K, Kuhen K, Phong WY, Patel V, Beer D, Walker JR, Duraiswamy J, Jiricek J, Keller TH, Chatterjee A, Tan MP, Ujjini M, Rao SPS, Camacho L, Bifani P, Mak PA, Ma I, Barnes SW, Chen Z, Plouffe D, Thayalan P, Ng SH, Au M, Lee BH, Tan BH, Ravindran S, Nanjundappa M, Lin X, Goh A, Lakshminarayana SB, Shoen C, Cynamon M, Kreiswirth B, Dartois V, Peters EC, Glynne R, Brenner S, Dick T. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nature Communications. 2010;1:57. doi: 10.1038/ncomms1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodrigue S, Provvedi R, Jacques PE, Gaudreau L, Manganelli R. The sigma factors of Mycobacterium tuberculosis. FEMS Microbiology Reviews. 2006;30:926–941. doi: 10.1111/j.1574-6976.2006.00040.x. [DOI] [PubMed] [Google Scholar]
- Ryndak MB, Wang S, Smith I, Rodriguez GM. The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. Journal of Bacteriology. 2010;192:861–869. doi: 10.1128/JB.00223-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, Barber DL. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease. PLOS Pathogens. 2016;12:e1005667. doi: 10.1371/journal.ppat.1005667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Molecular Microbiology. 2003;48:77–84. doi: 10.1046/j.1365-2958.2003.03425.x. [DOI] [PubMed] [Google Scholar]
- Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. PNAS. 2003;100:12989–12994. doi: 10.1073/pnas.2134250100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saul MC, Philip VM, Reinholdt LG, Center for Systems Neurogenetics of Addiction. Chesler EJ. High-Diversity Mouse Populations for Complex Traits. Trends in Genetics. 2019;35:501–514. doi: 10.1016/j.tig.2019.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saunders BM, Frank AA, Orme IM, Cooper AM. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cellular Immunology. 2002;216:65–72. doi: 10.1016/s0008-8749(02)00510-5. [DOI] [PubMed] [Google Scholar]
- Shorter JR, Najarian ML, Bell TA, Blanchard M, Ferris MT, Hock P, Kashfeen A, Kirchoff KE, Linnertz CL, Sigmon JS, Miller DR, McMillan L, Pardo-Manuel de Villena F. Whole Genome Sequencing and Progress Toward Full Inbreeding of the Mouse Collaborative Cross Population. G3: Genes, Genomes, Genetics. 2019;9:1303–1311. doi: 10.1534/g3.119.400039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sigmon JS, Blanchard MW, Baric RS, Bell TA, Brennan J, Brockmann GA, Burks AW, Calabrese JM, Caron KM, Cheney RE, Ciavatta D, Conlon F, Darr DB, Faber J, Franklin C, Gershon TR, Gralinski L, Gu B, Gaines CH, Hagan RS, Heimsath EG, Heise MT, Hock P, Ideraabdullah F, Jennette JC, Kafri T, Kashfeen A, Kulis M, Kumar V, Linnertz C, Livraghi-Butrico A, Lloyd KCK, Lutz C, Lynch RM, Magnuson T, Matsushima GK, McMullan R, Miller DR, Mohlke KL, Moy SS, Murphy CEY, Najarian M, O’Brien L, Palmer AA, Philpot BD, Randell SH, Reinholdt L, Ren Y, Rockwood S, Rogala AR, Saraswatula A, Sassetti CM, Schisler JC, Schoenrock SA, Shaw GD, Shorter JR, Smith CM, St. Pierre CL, Tarantino LM, Threadgill DW, Valdar W, Vilen BJ, Wardwell K, Whitmire JK, Williams L, Zylka MJ, Ferris MT, McMillan L, Manuel de Villena FP. Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research. Genetics. 2020;216:905–930. doi: 10.1534/genetics.120.303596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith CM, Proulx MK, Olive AJ, Laddy D, Mishra BB, Moss C, Gutierrez NM, Bellerose MM, Barreira-Silva P, Phuah JY, Baker RE, Behar SM, Kornfeld H, Evans TG, Beamer G, Sassetti CM, Bloom BR, Kaushal D, Behr M. Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype. MBio. 2016;7:e01516-16. doi: 10.1128/mBio.01516-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith CM, Sassetti CM. Modeling Diversity: Do Homogeneous Laboratory Strains Limit Discovery? Trends in Microbiology. 2018;26:892–895. doi: 10.1016/j.tim.2018.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith CM, Proulx MK, Lai R, Kiritsy MC, Bell TA, Hock P, Pardo-Manuel de Villena F, Ferris MT, Baker RE, Behar SM, Sassetti CM, Vance R. Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice. MBio. 2019;10:e02791-19. doi: 10.1128/mBio.02791-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sousa J, Cá B, Maceiras AR, Simões-Costa L, Fonseca KL, Fernandes AI, Ramos A, Carvalho T, Barros L, Magalhães C, Chiner-Oms Á, Machado H, Veiga MI, Singh A, Pereira R, Amorim A, Vieira J, Vieira CP, Bhatt A, Rodrigues F, Rodrigues PNS, Gagneux S, Castro AG, Guimarães JT, Bastos HN, Osório NS, Comas I, Saraiva M. Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1β production. Nature Communications. 2020;11:1949. doi: 10.1038/s41467-020-15832-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Springer B, Master S, Sander P, Zahrt T, McFalone M, Song J, Papavinasasundaram KG, Colston MJ, Boettger E, Deretic V. Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infection and Immunity. 2001;69:5967–5973. doi: 10.1128/IAI.69.10.5967-5973.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Srivastava A, Morgan AP, Najarian ML, Sarsani VK, Sigmon JS, Shorter JR, Kashfeen A, McMullan RC, Williams LH, Giusti-Rodríguez P, Ferris MT, Sullivan P, Hock P, Miller DR, Bell TA, McMillan L, Churchill GA, de Villena FP-M. Genomes of the Mouse Collaborative Cross. Genetics. 2017;206:537–556. doi: 10.1534/genetics.116.198838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. PNAS. 2003;100:13001–13006. doi: 10.1073/pnas.2235593100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svenson KL, Gatti DM, Valdar W, Welsh CE, Cheng R, Chesler EJ, Palmer AA, McMillan L, Churchill GA. High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics. 2012;190:437–447. doi: 10.1534/genetics.111.132597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thuong NTT, Tram TTB, Dinh TD, Thai PVK, Heemskerk D, Bang ND, Chau TTH, Russell DG, Thwaites GE, Hawn TR, Caws M, Dunstan SJ. MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage. Genes and Immunity. 2016;17:419–425. doi: 10.1038/gene.2016.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turkarslan S, Peterson EJR, Rustad TR, Minch KJ, Reiss DJ, Morrison R, Ma S, Price ND, Sherman DR, Baliga NS. A comprehensive map of genome-wide gene regulation in Mycobacterium tuberculosis. Scientific Data. 2015;2:150010. doi: 10.1038/sdata.2015.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Q, Boshoff HIM, Harrison JR, Ray PC, Green SR, Wyatt PG, Barry CE. PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science (New York, N.Y.) 2020;367:aav5912. doi: 10.1126/science.aav5912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wirth T, Hildebrand F, Allix-Béguec C, Wölbeling F, Kubica T, Kremer K, van Soolingen D, Rüsch-Gerdes S, Locht C, Brisse S, Meyer A, Supply P, Niemann S. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLOS Pathogens. 2008;4:e1000160. doi: 10.1371/journal.ppat.1000160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woong Park S, Klotzsche M, Wilson DJ, Boshoff HI, Eoh H, Manjunatha U, Blumenthal A, Rhee K, Barry CE, Aldrich CC, Ehrt S, Schnappinger D. Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. PLOS Pathogens. 2011;7:e1002264. doi: 10.1371/journal.ppat.1002264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA, ACS and GC6-74 cohort study groups A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet (London, England) 2016;387:2312–2322. doi: 10.1016/S0140-6736(15)01316-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, Schuster BM, Trauner A, Wallis D, Galaviz S, Huttenhower C, Sacchettini JC, Behar SM, Rubin EJ. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell. 2013;155:1296–1308. doi: 10.1016/j.cell.2013.10.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang J, Teh M, Kim J, Eva MM, Cayrol R, Meade R, Nijnik A, Montagutelli X, Malo D, Jaubert J. A Loss-of-Function Mutation in the Integrin Alpha L (Itgal) Gene Contributes to Susceptibility to Salmonella enterica Serovar Typhimurium Infection in Collaborative Cross Strain CC042. Infection and Immunity. 2019;88:e00656-19. doi: 10.1128/IAI.00656-19. [DOI] [PMC free article] [PubMed] [Google Scholar]